GB2226817A - Intermediates for agriculturally useful acrylic acid derivatives - Google Patents

Intermediates for agriculturally useful acrylic acid derivatives Download PDF

Info

Publication number
GB2226817A
GB2226817A GB9001442A GB9001442A GB2226817A GB 2226817 A GB2226817 A GB 2226817A GB 9001442 A GB9001442 A GB 9001442A GB 9001442 A GB9001442 A GB 9001442A GB 2226817 A GB2226817 A GB 2226817A
Authority
GB
United Kingdom
Prior art keywords
optionally substituted
hydrogen
formula
compounds
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9001442A
Other versions
GB2226817B (en
GB9001442D0 (en
Inventor
Vivienne Margaret Anthony
John Martin Clough
Paul Defraine
Christopher Richard Ay Godfrey
Ian Ferguson
Patrick Jelf Crowley
Michael Gorden Hutchings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868609454A external-priority patent/GB8609454D0/en
Priority claimed from GB868630825A external-priority patent/GB8630825D0/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of GB9001442D0 publication Critical patent/GB9001442D0/en
Publication of GB2226817A publication Critical patent/GB2226817A/en
Application granted granted Critical
Publication of GB2226817B publication Critical patent/GB2226817B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C07D213/643—2-Phenoxypyridines; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/58—Two sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Compounds of general formula (II): <IMAGE> and stereoisomers thereof; wherein X, Y and Z, which are the same or different, are hydrogen or various substituents; R<1> is optionally substituted alkyl; A is either an oxygen atom or S(O)n wherein n is 0, 1 or 2; R<10> is hydrogen or a protecting group for a phenol or thiophenol group; and R<9> is optionally substituted alkyl, hydrogen or a metal atom; provided that - when R<10> is hydrogen then R<9> is not hydrogen or a metal atom, - when A is oxygen, R<1> and R<9> are both methyl and R<10> is either hydrogen or a benzyl group then none of X, Y and Z is hydrogen, - when R<9> is hydrogen A is oxygen, R<1> is methyl and R<10> is a benzyl group then none of X, Y and Z is hydrogen, are used in the production of acrylic acid derivatives which have in particular fungcidal activity.

Description

FUUG ICIDES This invention relates to derivatives of acrylic acid useful in agriculture (especially as fungicides but also as plant growth regulators, insecticides and nematocides), to processes for preparing them, to agricultural (especially fungicidal) compositions containing them, and to methods of using them to combat fungi, especially fungal infections in plants, to regulate plant growth and to kill or control insect or nematode pes- > .
The invention provides a compound having the formula (I):
and stereoisomers thereof1 wherein W is a substituted pyridinyl or substituted pyrimidinyl group linked to A by any of its ring carbon atoms; A is either an oxygen atom or S(O), wherein n is 0, i or 2;X, Y and Z, which are the same or different, are hydrogen or halogen atoms, or hydroxy, optionally substituted alkyl (including haloalkyl), optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy, (including haloalkoxy), optionally substituted alkylthio, optionally substituted aryloxy, optionally substituted arylalkoxy, optionally substituted acyloxy, optionally substituted amino, optionally substituted acylamino, nitro, cyano, -C02R31 -CONR4R5, -COR6 or -s(o)mR7 (wherein rn is C, 1 or 2) groups1 or any two of the groups X, Y and Z, when they are in adjacent positions on the phenyl ring, may ,oin to form a fused ring, either aromatic or aliphatic, optionally containing one or more heteroatoms;R1 and R, which are the same or different, are optionally substituted alkyl (including fluoroalkyl) groups provided that when W is 5-trifluoromethylpyridin-2-yl, A is oxygen, X is hydrogen, and R1 and R2 are both methyl, Y and Z are not both hydrogen, Y is not F, C1, methyl, nitro, 5-CF3, 5-SCH3 or 4-(CH3)2N if Z is hydrogen and Y and Z together are not 3-nitro-5-chloro, 3,5-dinitro, 4,5-dimethoxy or 4,5methylenedioxy; and R3, R4, R5, R6 and R7, which are the same or different, are hydrogen atoms or optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl or optionally substituted aralkyl groups; and metal complexes thereof.
The compounds of the invention contain at least one carbon-carbon double bond, and are sometimes obtained in the form of mixtures of geometric isomers. However, these mixtures can be separated into individual isomers, and this invention embraces such isomers and mixtures thereof in all proportions including those which consist substantially of the (Z)-isomer and those which consist substantially of the (E)-isomer.
The individual isomers which result rom te unsymmetrically substituted double bond of the acrylate group are identified by the commonly used terms "E" and "Z". These terms are defined according to the Cahn-Incold- Prelog system which is fully described in the literature (see, for example, J March, "Advanced Organic Chemistry," 3rd edition, Wiley-Interscience, page 109 et seq).
Usually one isomer is more fungicidally active then the other; the more active isomer being the one in which the group -OR2 is on the same side of the double bond as the phenyl ring. In the case of the compounds of the present invention this is the (E)-isomer. The ()isomers form a preferred embodiment of the invention.
The formula
used hereinafter signifies a separable mixture of both geometric isomers about the acrylate double bond, i.e.
Alkyl groups, wherever present as a group or moiety in, for example, "alkoxy", "alkylthio" and "aralkyl", can be in the form of straight or branched chains, and contain preferably 1 to 6, more preferably 1 to 4, carbon atoms; examples are methyl, ethyl, propyl, (n- or iso-propyl) and butyl 'n-, sec-, iso- or t-butyl).
R1 and R21 which are optionally substituted alkyl groups, are preferably optionally substituted C14, particularly C1~2, alkyl groups. A preferred substituent is fluorine of which one or more atoms may be present. It is particularly preferred that R1 and R2 are both methyl, either one or both methyl groups being optionally substituted by one, two or three fluorine atoms.
Halogen atoms, wherever referred to are particularly fluorine, chlorine or bromine atoms and especially fluorine or chlorine atoms.
Cycloalkyl is preferably C36 cycloalkyl, for example oyclohexyl, and cycloalkylalkyl is preferably C36 cycloa1kyl(C14)alkyl, for example, cyclopropylethyl.
Alkenyl and alkynyl groups preferably contain 2 to 6, more preferably 2 to 4, carbon atoms in the form of straight or branched chains. Examples are ethenyl, allyl and propargyl. Aryl is preferably phenyl and aralkyl is preferably benzyl, phenylethyl or phenyl n-propyl.
optionally substituted alkyl includes in particular, haloalkyl, hydroxyalkyl, alkoxyalkyl, optionally substituted aralkyl, especially optionally substituted phenylalkyl, and optionally substituted aryloxyalkyl, especially optionally substituted phenoxyalkyl; optionally substituted alkenyl includes optionally substituted phenylalkenyl, especially optionally substituted phenylevhenyl; optionally substituted aryloxy includes optionally substituted phenyloxy; and optionally substituted arylalkoxy includes optionally substituted benzyloxy. Optional substituents for "alkoxy" and "alkylthio" include those described above for "alkyl".
Substituents which may be present in any optionall subatituted aryl or heteroaryl moiety include one cr more of the following; halogen, hydroxy, C14 alkyl (especially methyl and ethyl), C1-4 alkoxy (especially methoxy), halo (C1-4)alkyl(especially trifluoromethyl), halo (C1-4)alkoxy (especially trifluoromethoxy), C14 alkylthio (especially methylthio), (C1-4)alkoxy(C1-4)alkyl, C36 cycloalkyl, C3-6 cycloalkyl(C14)alkyl, aryl (especially phenyl), aryloxy (especially phenloxy), aryl(C1-4)alkyl (especiall benzyl, phenylethyl and phenyl n-propyl), aryl C1-4 alkoxy (especially benzyloxy), aryloxy(C1-4)alkyl (especially phenyloxymethyl), acyloxy (especially acetyloxy and benzoyloxy), cyano, thiocyanato, nitro, -NR'R", -NBCOR', -NHCONR'R", -CONR'R", -COOR', -OSO2R', -S02R', -COR', -OCOR', -CR'=NR" or -N=CR'R" in which R' and R" are independently hydrogen, C1-4alkyl, C1-4alkoxy, C1-4 alkylthio, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C14 alkyl or C1 alkoxy. Optionally substituted amino, acylamino and acyloxy groups include the groups -NR'R", -NHCOR' and -OCOR' in which R' and R" are as defined above.
The substituents on the substituted pyridinyl or substituted pyrimidinyl ring W, which are the same or different, include any of the values given for X, Y and In particular, they include halogen atoms, or hydroxy, optionally substituted alkyl (including haloalkyl), especially C1-4 alkyl, optionally substituted alkenyl, especially C3-C4 alkenyl, optionally substituted aryl, optionally substituted alkynyl, especially C3-C4 alkynyl optionally substituted alkoxy (including haloalkoxy), especially C1-4 alkoxy, optionally substituted aryloxy, optionally substituted heterocyclyloxy, (especially heteroaryloxy), optionally substituted aryl, optionally substituted heterocyclyl, (especially 5- and 6-memberes carbon-nitrogen rings eg.
nitro, cyano, -fR'R", -NHCOR', -CONR'R", -OCOR', -C02R, -COR', -CH=NOR", -CH2NR'R", -CH2OR', -CH2NHCOR', -CH2OCOR', or S(o)Rl (wherein rn is 0, 1 or 2) groups or any two of the substltuents on the pyridinyl or pyrimidinyl rings, when they are in adjacent positions on the ring may join to form an optionally substituted fused ring, either aromatic or aliphatic, optionally containing one or more heteroatoms; and R', R", R3, R4, R5, R6 and R7 are as defined above.
Pyridines and pyrimidines with hydroxy substituents in appropriate positions may also exist in the corresponding tautomeric oxo-forms, ie. as the corresponding pyridones and pyrimidones, respectively. It is intended that when there is a hydroxy substituent on the pyridinyl or pyrimidinyl ring W the present invention should include all such tautomeric forms and mixtures thereof (see, for example, G R Newkome and W W Paudler, Contemporary Heterocyclic Chemistry, Wiley - Interscience pp236-241).
Preferred substituent haloalkyl and haloalkoxy groups are halo C14 alkyl and halo (C1-4)alkoxy groups.
Haloalkyl includes particularly trihalomethyl and especially trifluoromethyl (except where otherwise indicated).
Preferred aryl groups, or moieties, Ee.g. as in aryloxy] are phenyl whilst substituents on a substituted amino group, or moiety are preferably C14 alkyl.
Preferred heterocyclic groups, or moieties (e.g. as in heterocyclyl or heterocyclyloxy) are, for example1 2-, 3-, or 4-optionally substituted pyridines or 2-, 4- or 5optionally substituted pyrimidines.
In one particular aspect, the invention provides compounds having the formula (I)
and stereoisomers thereof, wherein W is a substituted pyridinyl or a substituted pyrimidinyl group linked to A by any one of its carbon atoms and bearing substituents as defined above; A is either an oxygen atom or S(O)n wherein n is O, 1 or 2;X, Y and Z, which are the same or different, are hydrogen, fluorine, chlorine or bromine atoms, or hydroxy, C14 alkyl, C25 alkenyl, C25 alkynyl, phenyl, C14 haloalkyl, C14 alkoxy, phenoxy, benzyloxy or mono- or dialkylamino groups, or any two of the groups X, Y and Z, when they are in adjacent positions on the phenyl ring, join to form a fused aromatic ring; wherein the aliphatic moieties of any of the foregoing are optionally substituted with one or more C14 alkoxy groups, fluorine, chlorine or bromine atoms, phenyl rings which themselves are optionally substituted, heterocyclic rings which are either aromatic or non-aromatic and are themselves optionally substituted, nitro, amino, cyano, hydroxyl or carboxyl groups, and wherein the phenyl moieties of any of the foregoing are optionally substituted with one or more fluorine, chlorine or bromine atoms, phenyl rings, C1-4 alkyl, C14 alkoxy, cyano, amino, nitrile, hydroxyl or carboxyl groups; and R1 and R2, which are the same or different, are C1-4 alkyl (especially both methyl), each optionally substituted with one, two or three halogen (especially fluorine), atoms provided that when W is 5trifluoromethylpyridin-2-yl, A is oxygen, X is hydrogen, and R1 and R2 are both methyl, Y and Z are not both hydrogen, Y is not F, C1, methyl, nitro, 5-CF3, 5-SCH3 or 4-(CH3)2N if Z is hydrogen and Y and Z together are not 3nitro-5-chloro, 3,5-dinitro, 4,5-dimethoxy or 4,5methylenedioxy.
When one or more of X, Y and Z are other than hydrogen it is preferred that they are single atoms or sterically small groups such as fluorine, chlorine, bromine, hydroxy, methyl, methoxy, trifluoromethyl, methylamino and dimethylamino. It is further preferred that one of such substituents occupies the 5-position of the phenyl ring (the acrylate group being attached to the l-position) as this r.ay offer advantages with respect to. phytotoxicity especially where there is present only a single substituent such as chlorine.
In another aspect the invention provides compounds having the formula (Ia)
and stereoisomers thereof, wherein A is 5(O) n wherein n is 0, 1 or 2, or preferably, an oxygen atom; W is a substituted pyridinyl or a substituted pyrimidinyl group linked to A by any one of its carbon atoms, the substituents on the pyridinyl or pyrimidinyl rings, which are the same or different, being one or more halogen atoms, or hydroxy, optionally substituted alkyl (including haloalkyl), optionally substituted alkenyl, optionally substituted aryl, optionally substituted alkynyl, optionally substituted alkoxy, (including haloalkoxy), optionally substituted aryloxy, optionally substituted heterocyclyloxy, optionally substituted aryl, optionally substituted heterocyclyl, optionally substituted acyloxy, optionally substituted amino, optionally substituted acylamino, nitro, cyano, -CO2R3, -CONR4R5, -COR6 or S(O)R' (wherein m = 0, 1 or 2) groups; provided that when W is - trifluoromethylpyridin-2-yl, A is oxygen, X is hydrogen, and R and R2 are both methyl, Y and Z are not both hydrogen, Y is not F, C1, methyl, nitro, 5-CF3, 5-SCH3 or 4-(CH3)2N if Z is hydrogen and Y and Z together are not 3nitro-5-chloro, 3,5-dinitro, 4,5-dimethoxy or 4,5methylenedioxy; and R3, R4, R5, R6 and 7 are as defined above.
Preferred substituents on the pyridinyl or pyrimiJinsl ring are chlorine, fluorine, bromine, methyl, trifluoromethyl (except where otherwise indicated), trichlorornethyl and methoxy.
In a still further aspect the invention provides compounds having the formula (Ib)
where Q is methyl, trifluoromethyl (but not 5-trifluoromethyl), methoxy, bromine, fluorine or, especially, chlorine.
Q is preferably in the 4-, 5- or 6- position of the pyridine ring, and more preferably in the 4- position we it is methyl, for instance.
The invention is illustrated by the compounds presented in Tables I to III below.
TABLE I
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 1 3'-Fluoropyridin-2'-yl H H H E 2 3'-Chloropyridin-2'-yl H H H E 3 3'-Bromopyridin-2'-yl H H H E 4 3'-Methylpyridin-2'-yl H H H E 5 3'-(Trifluoromethyl)pyridin-2'-yl H H H E 6 3'-Methoxypyridin-2'-yl H H H E 7 4'-Fluoropyridin-2'-yl H H H E 8 4'-Chloropyridin-2'-yl H H H E 9 4'-Biomopyridin-2'-yl H H H E 10 4'-Methylpyridin-2'-yl H H H gum 7.37 E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 11 4'-(Trifluoromethyl)pyridin-2'-yl H H H gum 7.44 E 12 4'-Methoxypyridin-2'-yl H H H E 13 5'-Fluoropyridin-2'-yl H H H E 14 5'-Chloropyridin-2'-yl H H H 77-8 7.41 E 15 5'-Bromopyridin-2'-yl H H H 104.6-105.4 7.43 E 16 5'-Methylpyridin-2'-yl H H H gum 7.42 E 17 6'-Methoxypyridin-2'-yl H H H E 18 6'-Fluoropyridin-2'-yl H H H E 19 6'-Chloropyridin-2'-yl H H H E 20 6'-Bromopyridin-2'-yl H H H E 21 6'-Methylpyridin-2'-yl H H H gum 7.40 E 22 6'-(Trifluoromethyl)pyridin-2'-yl H H H gum 7.42 E 23 6'-Methoxypyridin-2'-yl H H H E 24 2'-Fluoropyridin-3'-yl H H H E 25 2'-Chloropyridin-3'-yl H H H E 26 2'-Bromopyridin-3'-yl H H H E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 27 2'-Methylpyridin-3'-yl H H H E 28 2'-(Trifluoromethyl)pyridin-3'-yl H H H E 29 2'-Methoxypyridin-3'-yl H H H E 30 4'-Fluoropyridin-3'-yl H H H E 31 4'-Chloropyridin-3'-yl H H H E 32 4'-Bromopyridin-3'-yl H H H E 33 4'-Methoxypyridin-3'-yl H H H E 34 4'-(Trifluoromethyl)pyridin-3'-yl H H H E 35 4'-Methoxypyridin-3'-yl H H H E 36 5'-Fluoropyridin-3'-yl H H H E 37 5'-Chloropyridin-3'-yl H H H E 38 5'-Bromopyridin-3'-yl H H H E 39 5'-Methoxypyridin-3'-yl H H H E 40 5'-(Trifluoromethyl)pyridin-3'-yl H H H E 41 5'-Methoxypyridin-3'-yl H H H E 42 6'-Fluoropyridin-3'-yl H H H E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 43 6'-Chloropyridin-3'-yl H H H E 44 6'-Bromopyridin-3'-yl H H H E 45 6'-Methylpyridin-3'-yl H H H E 46 6'-(Trifluoromethyl)pyridin-3'-yl H H H E 47 6'-Methoxypyridin-3'-yl H H H E 48 2'-Fluoropyridin-4'-yl H H H E 49 2'-Chloropyridin-4'-yl H H H E 50 2'-Bromopyridin-4'-yl H H H E 51 2'-Methoyxpyridin-4'-yl H H H E 52 2'-(Trifluoromethyl)pyridin-4'-yl H H H E 53 2'-Methoxypyridin-4'-yl H H H E 54 3'-Fluoropyridin-4'-yl H H H E 55 3'-Chloropyridin-4'-yl H H H E 56 3'-Bromopyridin-4'-yl H H H E 57 3'-Methylpyridin-4'-yl H H H E 58 3'-(Trifluoromethyl)pyridin-4'-yl H H H E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 59 3'-Methoxypyridin-4'-yl H H H E 60 4'-Fluoropyrimidin-2'-yl H H H E 61 4'-Chloropyrimidin-2'-yl H H H 120-121.5 7.40 E 62 4'-Bromopyrimidin-2'-yl H H H E 63 4'-Methylpyrimidin-2'-yl H H H E 64 4'-(Trifluoromethyl)pyrimidin-2'-yl H H H E 65 4'-Methoxypyrimidin-2'-yl H H H E 66 5'-Fluoropyrimidin-2'-yl H H H E 67 5'-Chloropyrimidin-2'-yl H H H gum 7.40 E 68 5'-Bromopyrimidin-2'-yl H H H E 69 5'-Methylpyrimidin-2'-yl H H H E 70 5'-(Trifluoromethyl)pyrimidin-2'-yl H H H E 71 5'-Methoxypyrimidin-2'-yl H H H E 72 2'-Fluoropyrimidin-4'-yl H H H E 73 2'-Chloropyrimidin-4'-yl H H H E 74 2'-Bromopyrimidin-4'-yl H H H E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 75 2'-Methylpyrimidin-4'-yl H H H E 76 2'-(Trifluoromethyl)pyrimidin-4'-yl H H H E 77 2'-Methylpyrimidin-4'-yl H H H E 78 5'-Fluoropyrimidin-4'-yl H H H E 79 5'-Chloropyrimidin-4'-yl H H H E 80 5'-Bromopyrimidin-4'-yl H H H E 81 5'-Methoxypyrimidin-4'-yl H H H E 82 5'-(Trifluoromethyl)pyrimidin-4'-yl H H H E 83 5'-Methoxypyrimidin-4'-yl H H H E 84 6'-Fluoropyrimidin-4'-yl H H H E 85 6'-Chloropyrimidin-4'-yl H H H E 86 6'-Bromopyrimidin-4'-yl H H H E 87 6'-Methylpyrimidin-4'-yl H H H E 88 6'-(Trifluoromethyl)pyrimidin-4'-yl H H H E 89 6'-Methylpyrimidin-4'-yl H H H E 90 2'-Fluoropyrimidin-5'-yl H H H E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 91 2'-Chloropyrimidin-5'-yl H H H E 92 2'-Bromopyrimidin-5'-yl H H H E 93 2'-Methylpyrimidin-5'-yl H H H E 94 2'-(Trifluoromethyl)pyrimidin-5'-yl H H H E 95 2'-Methoxypyrimidin-5'-yl H H H E 96 4'-Fluoropyrimidin-5'-yl H H H E 97 4'-Chloropyrimidin-5'-yl H H H E 98 4'-Bromopyrimidin-5'-yl H H H E 99 4'-Methylpyrimidin-5'-yl H H H E 100 4'-(Trifluoromethyl)pyrimidin-5'-yl H H H E 101 4'-Methoxypyrimidin-5'-yl H H H E 102 5'-(Trifluoromethyl)pyridin-2'-yl 3-F 5-F H E 103 3'-Fluoro-5'-(trifluoromethyl)pyridin-2'-yl H H H E 104 5'-(Trifluoromethyl)pyridin-3'-yl 4-F H H E 105 3',6'-Dichloro-5'-(trifluoromethyl) H H H E pyridin-2'-yl TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 106 5',6'-Dichloro-3'-(trifluoromethyl)- H H H E pyridin-2'-yl 107 5'-Chloro-3'-(trifluoromethyl)pyridin- H H H E 2'-yl 108 3'-Chloro-5'-(trifluoromethyl)pyridin- H H H E 2'-yl 109 6'-Chloro-4'-cyanopyridin-2'-yl H H H E 110 3'-Cyano-5'-nitropyridin-2'-yl H H H E 111 2'-Chloro-6'-fluoropyridin-4'-yl H H H E 112 6'-Chloro-4'-fluoropyridin-2'-yl H H H E 113 4',6'-Difluoropyridin-2'-yl H H H E 114 3',5'-Dichloro-6'-fluoropyridin-2'-yl H H H E 115 6'-Methoxy-3'-nitropyridin-2'-yl H H H E 116 4'-Cyano-6'-fluoropyridin-2'-yl H H H E 117 6'-Chloro-5'-cyanopyridin-2'-yl H H H E 118 6'-Chloro-3'-cyanopyridin-2'-yl H H H E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 119 4'-Cyano-3',5',6'-trifluoropyridin- H H H E 2'-yl 120 4'-Cyano-2',5',6'-trifluoropyridin- H H H E 3'-yl 121 6'-Chloro-5'-nitropyridin-2'-yl H H H E 122 6'-Chloro-3'-nitropyridin-2'-yl H H H E 123 5'-Cyano-6'-fluoropyridin-2'-yl H H H E 124 3'-Cyano-6'-fluoropyridin-2'-yl H H H E 125 4',6'-Dicyanopyridin-2'-yl H H H E 126 5'-(Trichloromethyl)pyridin-2'-yl H H H E 127 5'-Cyanopyridin-2'-yl H H H 108.5-109.5 7.45 E 128 5'-Bromo-4'-(trifluoromethyl)pyridin-2'-yl H H H E 129 3'-Nitro-5'-(trifluoromethyl)pyridin-2'-yl H H H 113-114 7.41 E 130 5'-Formamidopyridin-2'-yl H H H gum obscured E 131 5'-Aminopyridin-2'-yl H H H gum 7.40 E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 132 2',3',5',6'-Tetrafluoropyridin-4'-yl H H H gum 7.55 E 133 5'-Nitropyridin-2'-yl H H H 107-109 7.45 E 134 4'-Methyl-5'-nitropyridin-2'-yl H H H E 135 5'-(Difluoromethyl)pyridin-2'-yl H H H E 136 5'-(Fluoromethyl)pyridin-2'-yl H H H E 137 4',6'-Difluoropyrimidin-2'-yl H H H gum 7.44 E 138 2',6'-Difluorpyrimidin-4'-yl H H H 79-80 7.46 E 139 2'-Chloro-6'-(trichloromethyl)pyrimidin- H H H 113-114 7.50 E 4'-yl 140 2',6'-Dichloropyrimidin-4'-yl H H H 93-94 7.46 E 141 5'-(Methoxycarbonyl)pyridin-2'-yl H H H Oil 7.32 E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 142 5'-Chloro-6'-fluoropyridin-2'-yl H H H E 143 5'-Chloro-6'-hydroxypyridin-2'-yl H H H E 144 5'-Chloro-6'-methoxypyridin-2'-yl H H H E 145 5'-Chloro-6'-cyanopyridin-2'-yl H H H E 146 5',6'-Dichloropyridin-2'-yl H H H E 147 6'-Bromo-5'-chloropyridin-2'-yl H H H E 148 5'-Chloro-6'-acetoxypyridin-2'-yl H H H E 149 5'-Bromo-6'-fluoropyridin-2'-yl H H H E 150 5'-Bromo-6'-chloropyridin-2'-yl H H H E 151 5'-Bromo-6'-cyanopyridin-2'-yl H H H E 152 5'-Bromo-6'-hydroxypyridin-2'-yl H H H E 153 5'-Bromo-6'-methoxypyridin-2'-yl H H H E 154 5',6'-Dibromopyridin-2'-yl H H H E 155 4'-Cyanopyridin-2'-yl H H H E 156 6'-Cyanopyridin-2'-yl H H H E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 157 5'-Chloropyridin-2'-yl 5-F H H E 158 5'-Chloropyridin-2'-yl 3-F 5-F H E 159 5'-Chloropyridin-2'-yl 4-F 6-F H E 160 5'-Chloropyridin-2'-yl 4-F 5-F 6-F E 161 5'-Chloropyridin-2'-yl 5-Cl H H E 162 5'-Chloropyridin-2'-yl 5-CH3 H H E 163 5'-Fluoropyridin-2'-yl 5-CH3O H H E 164 5'-Fluoropyridin-2'-yl 5-Cl H H E 165 # 5-Cl 3-F H Oil 7.43 E 166 4'-Chloro-6'-methylpyrimidin-2'-yl H H H 115-130 7.44 E 167 2'-Chloro-6'-fluoropyridin-4'-yl H H H Oil 7.46 E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 168 5'-Bromo-4'-(trifluoromethyl)pyridin- H H H E 2'-yl 169 4',5'-Dichloropyridin-2'-yl H H H E 170 4',5'-Dibromopyridin-2'-yl H H H E 171 5',6'-Dichloropyridin-2'-yl H H H E 172 4',6'-Dichloropyridin-2'-yl H H H E 173 4',6'-Dibromopyridin-2'-yl H H H E 174 5',6'-Dibromopyridin-2'-yl H H H E 175 4'-Bromo-5'-chloropyridin-2'-yl H H H E 176 6'-Bromo-5'-chloropyridin-2'-yl H H H E 177 5'-Bromo-4'-chloropyridin-2'-yl H H H E 178 5'-Bromo-6'-chloropyridin-2'-yl H H H E 179 6'-Bromo-4'-chloropyridin-2'-yl H H H E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 180 4'-Bromo-6'-chloropyridin-2'-yl H H H E 181 6'-Chloro-4'-methoxypyridin-2'-yl H H H E 182 6'-Bromo-4'-methoxypyridin-2'-yl H H H E 183 # H H H E 184 5'-(Benzyloxycarbonyl)pyridin-2'-yl H H H Gum 7.39 E 185 4'-Formylpyridin-2'-yl H H H Oil 7.40 E 186 5'-Formylpyridin-2'-yl H H H E 187 6'-Formylpyridin-2'-yl H H H E 188 4'-Cyanopyridin-2'-yl H H H E 189 6'-Cyanopyridin-2'-yl H H H E 190 5'-Hydroxymethylpyridin-2'-yl H H H E 191 6'-Chloro-4'-trifluoromethylpyrid-2'-yl H H H E TABLE I (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 192 6'-Chloro-4'-trifluoromethylpyrid-2'-yl H H H E 193 6'-Chloro-4'-methlpyridin-2'-yl H H H E 194 2',5'-Dichloro-6'-cyanopyridin-2'-yl H H H E 195 2',5'-Dichloro-6'-carboxypyridin-2'-yl H H H E 196 2',5'-Dichloro-6'-methoxycarbonyl- H H H E pyridin-2'-yl H H H E 197 6'-Trifluoromethylpyridin-2'-yl 198 6'-Methoxycarbonylpyridin-2'-yl H H H E 199 6'-Carboxypyridin-2'-yl H H H E 200 4'-Phenoxypyridin-2'-yl H H H E 201 5'-Phenoxypyridin-2'-yl H H H E 202 6'-Phenoxypyridin-2'-yl H H H E 203 6'-Chloropyridin-3'-yl H H H E * Chemical shift of singlet from olefinic proton on beta-methoxyacylate group (ppm from tetramethylsilone).
Solvent CDCl3.
+ Geometry of beta-methoxyacrylate group.
TABLE II
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 1 3'-Fluoropyridin-2'-yl H H H E 2 3'-Chloropyridin-2'-yl H H H E 3 3'-Bromopyridin-2'-yl H H H E 4 3'-Methylpyridin-2'-yl H H H E 5 3'-(Trifluoromethyl)pyridin-2'-yl H H H E 6 3'-Methoxypyridin-2'-yl H H H E 7 4'-Fluoropyridin-2'-yl H H H E 8 4'-Chloropyridin-2'-yl H H H E 9 4'-Bromopyridin-2'-yl H H H E 10 4'-Methylpyridin-2'-yl H H H E TABLE II (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 11 4'-(Trifluoromethyl)pyridin-2'-yl H H H E 12 4'-Methoxypyridin-2'-yl H H H E 13 5'-Fluoropyridin-2'-yl H H H E 14 5'-Chloropyridin-2'-yl H H H Oil 7.47 E 15 5'-Bromopyridin-2'-yl H H H Oil 7.47 E 16 5'-Methylpyridin-2'-yl H H H E 17 5'-Methoxypyridin-2'-yl H H H E 18 6'-Fluoropyridin-2'-yl H H H E 19 6'-Chloropyridin-2'-yl H H H E 20 6'-Bromopyridin-2'-yl H H H E 21 6'-Methylpyridin-2'-yl H H H E 22 6'-(Trifluoromethyl)pyridin-2'-yl H H H E 23 6'-Methoxypyridin-2'-yl H H H E 24 2'-Fluoropyridin-3'-yl H H H E 25 2'-Chloropyrid-3'-yl H H H E 26 2'-Bromopyrid-3'-yl H H H E TABLE II (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 27 2'-Methylpyridin-3'-yl H H H E 28 2'-(Trifluoromethyl)-pyridin-3'-yl H H H E 29 2'-Methoxypyridin-3'-yl H H H E 30 4'-Fluoropyridin-3'-yl H H H E 31 4'-Chloropyridin-3'-yl H H H E 32 4'-Bromopyridin-3'-yl H H H E 33 4'-Methylpyridin-3'-yl H H H E 34 4'-(Trifluoromethyl)pyridin-3'-yl H H H E 35 4'-Methoxypyridin-3'-yl H H H E 36 5'-Fluoropyridin-3'-yl H H H E 37 5'-Chloropyridin-3'-yl H H H E 38 5'-Bromopyridin-3'-yl H H H E 39 5'-Methylpyridin-3'-yl H H H E 40 5'-(Trifluoromethyl)pyridin-3'-yl H H H E 41 5'-Methoxypyridin-3'-yl H H H E 42 6'-Fluoropyridin-3'-yl H H H E TABLE II (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 43 6'-Chloropyridin-3'yl H H H E 44 6'-Bromopyridin-3'-yl H H H E 45 6'-Methylpyridin-3'-yl H H H E 46 6'-(Trifluoromethyl)pyridin-3'-yl H H H E 47 6'-Methoxypyridin-3'-yl H H H E 48 2'-Fluoropyridin-4'-yl H H H E 49 2'-Chloropyridin-4'-yl H H H E 50 2'-Bromopyridin-4'-yl H H H E 51 2'-Methylpyridin-4'-yl H H H E 52 2'-(Trifluoromethyl)pyridin-4'-yl H H H E 53 2'-Methoxypyridin-4'-yl H H H E 54 3'-Fluoropyridin-4'-yl H H H E 55 3'-Chloropyridin-4'-yl H H H E 56 3'-Bromopyridin-4'-yl H H H E 57 3'-Methylpyridin-4'-yl H H H E 58 3'-(Trifluoromethyl)pyridin-4'-yl H H H E TABLE II (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 59 3'-Methoxypyridin-4'-yl H H H E 60 4'-Fluoropyrimidin-2'-yl H H H E 61 4'-Chloropyrimidin'-2'-yl H H H E 62 4'-Bromopyrimidin-2'-yl H H H E 63 4'-Methylpyrimidin-2'-yl H H H E 64 4'-(Trifluoromethyl)pyrimidin-2'-yl H H H E 65 4'-Methoxypyrimidin-2'-yl H H H E 66 5'-Fluoropyrimidin-2'-yl H H H E 67 5'-Chloropyrimidin-2'-yl H H H E 68 5'-Bromopyrimidin-2'-yl H H H E 69 5'-Methylpyrimidin-2'-yl H H H E 70 5'-(Trifluoromethyl)pyrimidin-2'-yl H H H E 71 5'-Methoxypyrimidin-2'-yl H H H E 72 2'-Fluoropyrimidin-4'-yl H H H E 73 2'-Chloropyrimidin-4'-yl H H H E 74 2'-Bromopyrimidin-4'-yl H H H E TABLE II (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 75 2'-Methylpyrimidin-4'-yl H H H E 76 2'-(Trifluoromethyl)pyrimidin-4'-yl H H H E 77 2'-Methoxypyrimidin-4'-yl H H H E 78 5'-Fluoropyrimidin-4'-yl H H H E 79 5'-Chloropyrimidin-4'-yl H H H E 80 5'-Bromopyrimidin-4'-yl H H H E 81 5'-Methoxypyrimidin-4'-yl H H H E 82 5'-(Trifluoromethyl)pyrimidin-4'-yl H H H E 83 5'-Methoxypyrimidin-4'-yl H H H E 84 6'-Fluoropyrimidin-4'-yl H H H E 85 6'-Chloropyrimidin-4'-yl H H H E 86 6'-Bromopyrimidin-4'-yl H H H E 87 6'-Methylpyrimidin-4'-yl H H H E 88 6'-(Trifluoromethyl)pyrimidin-4'-yl H H H E 89 6'-Methoxypyrimidin-4'-yl H H H E 90 2'-Fluoropyrimidin-5'-yl H H H E TABLE II (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 91 2'-Chloropyrimidin-5'-yl H H H E 92 2'-Bromopyrimidin-5'-yl H H H E 93 2'-Methylpyrimidin-5'-yl H H H E 94 2'-(Trifluoromethyl)pyrimidin-5'-yl H H H E 95 2'-Methoxypyrimidin-5'-yl H H H E 96 4'-Fluoropyrimidin-5'-yl H H H E 97 4'-Chloropyrimidin-5'-yl H H H E 98 4'-Bromopyrimidin-5'-yl H H H E 99 4'-Methylpyrimidin-5'-yl H H H E 100 4'-(Trifluoromethyl)pyrimidin-5'-yl H H H E 101 4'-Methoxypyrimidin-5'-yl H H H E 102 5'-(Trifluoromethyl)pyridin-2'-yl 5-F H H E 103 5'-(Trifluoromethyl)pyridin-2'-yl H H H Oil 7.47 E 104 5'-Chloropyridin-2'-yl 5-F H H E TABLE II (cont)
Compound Melting Olefinic* Isomer + No. W X Y Z Point ( C) 105 5'-Chloropyridin-2'-yl 3-F 5-F H E 106 5'-Chloropyridin-2'-yl 4-F 5-F 6-F E 107 5'-Chloropyridin-2'-yl 5-Cl H H E 108 5'-Chloropyridin-2'-yl 5-CH3O H H E 109 5'-Chloropyridin-2'-yl 5-CH3 H H E 110 5'-Fluoropyridin-2'-yl 5-Cl H H E 111 5'-Fluoropyridin-2'-yl 5-Cl 3-F H E * Chemical shift of singlet from olefinic proton on beta-methoxyacrylate group (ppm from tetramethylsilane).
Solvent CDCl3 (unless otherwise stated).
+ Geometry of beta-methoxyacrylate group.
TABLE III
Compound Melting Olefinic* Isomer + No. W n X Y Z Point ( C) 1 5'-Bromopyridin-2'-yl 1 H H H gum 7.60 E 2 5'-Bromopyridin-2'-yl 2 H H H gum 7.24 E 3 5'-Chloropyridin-2'-yl 1 H H H E 4 5'-Chloropyridin-2'-yl 2 H H H E 5 5'-(Trifluoromethyl)- 1 5-F H H E pyridin-2'-yl * Chemical shift of singlet from olefinic proton on beta-methoxyacrylate group (ppm from tetramethylsilane).
Solvent CDCl3 (unless otherwise stated).
+ Geometry of beta-methoxyacrylate group.
TABLE IV TABLE IV : Selected proton NMR data Table IV shows selected proton NMR data for certain compounds described in Tables I, II and III and characterised therein as oils or gums. Chemical shifts are measured in ppm from tetramethylsilane, and deuterochloroform was used as solvent throughout. The following abbreviations are used br = broad t = triplet ppm = parts per s = singlet q = quartet million d = doublet m = multiplet
Compound No.
10 l 2.28 (3H,s); 3.52 (3H,s); 3.69 (3H,s); 6.77-7.98 (Table I) (7H, m); 7.37 (1H, s) ppm.
11 3.57 (3H,s); 3.72 (3H,s); 7.0-7.4 (m); 7.44 (Table I) (lH,s); 8.34 (H,d) ppm.
16 2.26 (3H,s); 3.56 (3H,s); 3.72 (3H,s); 6.65-7.98 (Table I) (7H,m); 7.42 (1H, s) ppm.
21 2.40 (3H,s); 3.51 (3H,s); 3.67 (3H,s); 6.4-7.55 (Table I) (7H,m); 7.4 (lH,s) ppm.
22 3.54 (3H,s); 3.74 (3H,s); 7.42 (lH,s) ppm.
(Table I)
67 3.60 (3H, s); 3.75 (3H, s); 7.20-7.4 (m); 7.40 (Table I) (1H,s); 8.40 (2H,s) ppm. 130 3.85 (3H,s); 3.95 (3H,s); 7.44-7.84 (9H,m) ppm. (Table I) 131 3.50 (3H,s); 3.60 (3H,s); 3.50 (2H br.s. ); 7.40 (Table I) (1H,s); 7.60 (lH,d) ppm. 132 3.70 (3H,s); 3.80 (3H,s); 7.55 (lH,s) ppm. (Table I) 133 3.60 (3H,s); 3.75 (3H,s); 6.95 (lH,d); 7.45 (Table I) (lH,s); 8.45 (lH,dd); 9.05 (lH,dd) ppm. 137 | 3.62 (3H,s); 3.76 (3H,s); 6.22 (1H,t); 7.20-7.50 (Table I) (4H,m); 7.44 (1H,s) ppm. 185 3.52 (3H,s); 3.72 (3H,s); 7.14-7.38 (6H, m); 7.40 (Table I) (lH,s); 8.36-8.38 (lH,m); 10.00 (lH,s). 14 3.60 (3H, s); 3.74 (3H, s); 6.68-6.72 (1H, d); 7.3 (Table -7.4 (4H,m); 7.47 (lH,s); 7.62-7.65 (lH,d); 8.3 II) (1H,s) ppm. 15 3.60 (3H, s); 3.74 (3H, s); 6.62-6.65 (1H, d); 7.3 (Table 7.5 (4H,m); 7.47 (lH,s); 7.62-7.64 (lH,d); 8.42 II) (1H, s) ppm. 103 3.60 (3H, s); 3.73 (3H, s); 6.78-6.82 (1H, d); (Table 7.35-7.55 (4H, m); 7.47 (1H, s); 7.65-7.68 (1H, d); II) 8.6 (1H, s) ppm.
165 3.51 (3H,s); 3.69 (3H,s); 7.01 (lH,d); 7.23-7.46 (Table I) (5H,m); 7.43 (lH,s); 7.62 (lH,t); 7.76 (lH,d); 7.85 (1H,d); 8.11 (lH,d) ppm. 167 3.64 (3H,s); 3.76 (3H,s); 6.31 (1H,d); 6.70 (Table I)l(lH,s); 7.11 (lH,d); 7.2-7.5 (4H,m) including 7.46 (lH,s) ppm. 112 .3.60 (3H,s); 3.73 (3H,s); 6.78-6.82 (lH,d); (Table 7.36-7.56 (4H,m); 7.47 (lH,s); 7.65-7.68 II) (1H, d); 8.60 (1H, s) ppm. 1 Table 3.68 (3H, s); 3.87 (3H, s); 7.16-7.20 (1H, m); III) 7.42-7.45 (2H,m); 7.60 (lH,s); 7.76-7.79 (lH,d); 7.86-7.93 (2H,m); 8.47 (lH,s) ppm. 2 Table 3.50 (3H,s); 3.55 (3H,s); 7.16-7.18 (lH,Z); III) j7.24 (lH,s); 7.54-7.65 (2H,m); 8.00 (2H,s); 8.36-8.41 (lH,d); 8.63 (1H,s) ppm.
The compounds of the invention having the general formula (I) can be prepared from substituted phenols or thiophenols of general formula (VII) by the steps shown in Scheme I. Throughout Scheme I the terms R1, R2, A, X, Y, Z and W are as defined above, L is a halogen atom or another good leaving group which can sometimes be a nitro group and R8 is hydrogen or a metal atom (such as a sodium atom).
Thus, compounds of general formula (I), which exist as geometric isomers which may be separated by chromatography, fractional crystallisation or distillation, can be prepared by treatment of phenylacetates of formula (IV) with a base (such as sodium hydride or sodium methoxide) and a formic ester such as methyl formate in a suitable solvent such as N,N- dimethylformamide and at a suitable temperature (step (b) of Scheme I). If a species of formula R2-L, wherein L is as defined above, is then added to the reaction mixture, compounds of formula (I) may be obtained (step (a) of Scheme I). If a prot1c acid is added to the reaction mixture, compounds of formula (III) wherein R8 is hydrogen are obtained.Alternatively, the species of formula (III) wherein R is a metal atom (especially an alkali metal atom such as sodium atom) may themselves be isolated from the reaction mixture.
Compounds of formula (III) wherein R8 is a metal atom can be converted into compounds of formula (I) by treatment with a species of formula R2-L, wherein L is as defined above, in a suitable solvent. Compounds of formula (I:Ij wherein R8 is hydrogen can be converted into compounds of formula (I) by successive treatments with a base (such as potassium carbonate) and a species of general formula 2,ill in a suitable solvent.
Alternatively, compounds of general formula (I) can be prepared from acetals of general formula (XIII) by elimination of the appropriate alkanol under either acidic or basic conditions, at a suitable temperature and often in a suitable solvent (step (c) of Scheme I). Examples of reagents or reagent mixtures which can be used for this transformation are lithium di-isopropylamide; potassium hydrogen sulphate (see, for example, T Yamada, H Hagiwara and H Uda, J. Chem. Soc., Chemical Communications, 1980, 838, and references therein); and triethylamine, often in the presence of a Lewis acid such as titanium tetrachloride (see, for example, K Nsunda and L Heresi, G.
Chem. Soc., Chemical Communications, 1985, 1000).
Acetals of general formula (XIII) can be prepared by treatment of alkyl silyl ketone acetals of general formula (XIV), wherein R is an alkyl group, with a trialkyl orthoformate of formula (R20)3CH in the presence of a Lewis acid such as titanium tetrachloride, at a suitable temperature and in a suitable solvent (see, for example, K Saigo, M Osaki and T Mukaiyama, Chemistry Letters, 1976, 769).
Alkyl silyl ketene acetals of general formula (XIV) can be prepared from esters of general formula (IV) by treatment with a base and a trialkylsilyl halide of general formula R3SiCl or R3SiBr, such as trimethylsilyl chloride, or a base and a trialkylsilyl triflate of general formula R3Si-OS02CF3, in a suitable solvent and at a suitable temperature (see, for example, C Ainsworth, F Chen and Y Kuo, J. Organometallic Chemistry, 1972, 46, 59).
It t is not always necessary to isolate the intermediates (XIII) and (XIV); under appropriate conditions, compounds of general formula (I) may be prepared from esters of general- formula (IV) in a "one pot" sequence by the successive addition of suitable reagents listed above.
Compounds of general formula (IV) can be prepared by esterification of compounds of general formula (V) by standard methods described in the chemical literature (Step (d) of Scheme I).
Compounds of general formula (V) can be prepared by the reaction of compounds of general formula (VII) with compounds of formula (VI) in the presence of a base (such as potassium carbonate) and, if necessary, a transition metal or transition metal salt catalyst (such as copperbronze) in a convenient solvent (such as N,N-dimethyl- formamide) (Step (e) of Scheme I).
Alternatively, compounds of general .or.-.ula (IV) can be prepared from esters of general formula (VIII) by reaction with compounds of general formula (VI) in the presence of a base (such as potassium carbonate) and, If necessary, a transition metal or transition metal salt catalyst (such as copper-bronze) in a convenient solvent (such as N,N-dimethylformamide) (Step (f) of Scheme I).
Esters of general formula (VIII) can be prepared by esterification of compounds of general formula (VII) by standard methods described in the chemical literature (Step (g) of Scheme I).
Compounds of general formula (VII) can be prepared by standard methods described in the chemical literature.
(For example, see, A. Clesse, W. Haefliger, D. Hauser, H.
U. Gubler, B. Dewald and M. Baggiolini, .Med.hem., 1981, 24, i465) and P D Clark and D M McKinnon, Can. J. Them., 1982, 60, 243 and references therein).
Compounds of general formula (I) wherein A is sulphur may be converted into compounds of formula (I) wherein A is S(O) or S(0)2 by standard methods of oxidation as described in the chemical literature, using, for example, a peracid such as meta-chloroperbenzoic acid, in a suitable solvent and at a suitable temperature.
Alternatively, compounds of the invention having the general formula (I) can be prepared from phenylacetates C general formula (X'I) by the steps shown in Scheme II.
Throughout Scheme II the terms R1, R2, R8, A, W, X, Y, Z and L are as defined above, and M is a protecting group for a phenol or thiophenol group.
Thus compounds of general formula (I) can be-prepared by reaction of compounds of general formula (IX) with compounds of general formula (VI) in the presence of a base (such as potassium carbonate) and, if necessary, a transition metal or transition metal salt catalyst in a convenient solvent (such as N,N-dimethylformamide) (step (h) of Scheme II).
Compounds of general formula (IX) can be prepared from protected phenol or thiophenol derivatives of general formula (X) by standard deprotection procedures as set out in the chemical literature (step (i) of Scheme II). For example, phenols of general formula (IX, A is 0) can be prepared from benzyl ethers of general formula (X, A is 0, M is CH2Ph) by hydrogenolysis in the presence of a suitable catalyst (such as palladium supported on carbon).
Compounds of general formula (X), in which the group Ni is a standard phenol or thiophenol protecting group (such as benzyl), can be prepared by treatment of phenylacetates of formula (XII) with a base (such as sodium hydride or sodium methoxide) and a formic ester (such as methyl formate) in a suitable solvent such as N,N-dimethylformamide and at a suitable temperature (step (k) of Scheme II). If a species of formula R2-l,, wherein L is as defined above, is then added to the reaction mixture, compounds of formula (X) may be obtained (step (j) of Scheme II). t rio tic acid is added to the reaction mixture, compounds of formula (XI) wherein R8 is hydrogen are obtained.
Alternatively, the species of formula (XI) wherein Ko Fs a metal atom (especially an alkali metal atom such as a sodium atom) may themselves be isolated from the reaction mixture.
Compounds of formula (XI) wherein R8 is a metal atom can be converted into compounds of formula (X) by treatment with a species of formula R2-L, in a suitable solvent.
Compounds of formula (XI) wherein R8 is hydrogen can be converted into compounds of formula (X) by successive treatment with a base (such as potassium carbonate) and a species of formula R2-L.
Compounds of general formula (XII) can be prepared from compounds of general formula (VIII ) by standard methods described in the chemical literature.
Scheme I
Scheme II
Alternatively, compounds of the invention having the general formula (I) can be prepared from substituted benzenes of general formula (XIX) by the steps shown in Scheme III. Throughout Scheme III the terms R1, R21 A, W, X, Y and Z are as defined above, D is hydrogen or halogen and E is a metal atom (such as a lithium atom) or a metal atom plus an associated halogen atom (such as MgI, gBr or MgCl).
Thus, compounds of general formula (I) can be prepared by treatment of ketoesters of general formula (XV) with phosphoranes of general formula (XVI) in a convenient solvent such as diethyl ether (see, for example, EP-A-0044448 and EP-A-0178826 (Step (c) of Scheme III).
Ketoesters of general forla (XV) can be prepared by treatment of metallated species (XVI I) with an oxalate (XVIII) in a suitable solvent such as diethyl ether or tetrahydrofuran. The preferred method often involves slow addition of a solution of the metallated species (XVII) to a stirred solution of an excess of the oxalate (XVIII) (see, for example, L M Weinstock, R B Currie and A V well, Synthetic Communications, 1981, 11, 943, and references therein) (step (m) of Scheme III).
The metallated species (XVII) in which E is MgI, MgBr or MgCl (Grignard reagents) can be prepared by standard methods from the corresponding aromatic halides (XIX) in which D is I, Br or Cl respectively. With certain substituents X, Y and Z, the metallated species (XVII) in which E is Li can be prepared by direct lithiation of compounds (XIX) in which D is H using a strong lithium base such as n-butyl-lithium or lithium di-isopropylamide (see, for example, H W Gschwend and H R Rodriguez, Organic Reactions, 1979, 26, 1) (step (n) of Scheme III).
Compounds of general formula (XIX) can be prepared by standard methods described in the chemical literature. Scheme III
Alternative methods for the Preparation of Xetoesters of general formula (XV) are described in the chemical literature (see, for example, D C Atkinson, K E Godfrey, 3 Meek, J F Saville and M R Stillings, J. fiend. Chem., 1983, 26, 1353; D Horne, J Gaudino and W J Thompson, Tetrahedron Lett., 1984, 25, 3529; and G P Axiotis, Tetrahedron Lett., 1981, 22, 1509).
Methods for preparing compounds of the invention having the general formula (I), as described in Schemes I and II are generally applicable where W in general formula (I) is a substituted 2-pyridinyl, or a 2- or 4pyrimidinyl group, and where W is a 4-pyridinyl group containing strong electron withdrawing substituents such as nitro, trifluoromethyl or fluoro. However for compounds of general formula (I) where W is a substituted 3- or 4-pyridinyl group the methods shown in Scheme II may not be generally applicable.
Also, although compounds of the invention having the general formula (I) where W is a substituted 3- or 4-pyridinyl group may be prepared from compounds of general formula (IV) by steps (a), (b) and (2) as shown in Scheme I, the preparation of compounds of general formula (IV) where W is a substituted 3- or 4-pyridinyl group may not be generally prepared by the steps (e) and (f) in Scheme I. Therefore an alternative method of preparation of compounds of general formula (IV) may need to be used.
In general, compounds of formula (IV) where W is a substituted 3- or 4-pyridinyl group, may preferably be prepared by the route shown in Scheme I.
Thus, in Scheme IV compounds of formula (IV) where W is a substituted 3- or 4-pyridinyl group can be prepared from compounds of formula (XX) where W is a substituted 3- or 4-pyridinyl group.
Scheme IV
Throughout Scheme IV, A, X, Y, Z and L are as defined above for Schemes I-III and T is any group that can be converted by standard methods in the literature.
in one or more steps, into an acetic ester side chain of structure CH2COOR1 as shown in formula (IV). For example, T may be a formyl group or any group that is capable of being transformed into a formyl group, such as a formyl acetal which may be hydrolysed by aqueous acid to the formyl group or such as a nitrile which may be reduced to the formyl group by metal hydride reduction (see, for example,'A E G Miller, J W Bliss and L H Schwartzmann, J. Org. Chem., 1959, 24, 627) or by Raney Alloy in formic acid (see, for example, van Es and Staskun, J. Chem. Soc.
1965, 5775). When T is a formyl group, it may then be converted into the acetic ester residue CH2COOR1 by reaction with methyl methylsulphinylmethylsulphide (CH3SOCH2SCH3 ) (see, for example, K Ogura and G Tsuchihashi, Tetrahedron Lett., 1972, 1383-6), followed by hydrolysis with an alcohol R1OH in the presence of an acid such as hydrogen chloride. For example T may also be a group such as a methyl group which can be halogenated, for example by bromine or N-bromosuccinimide, to give a halomethyl group which can then be treated with cyanide ion to give a cyano methyl group, which in turn can be hydrolysed to the acetic ester residue CH2COOR1 by methods well known in the literature. T may also be for example a carboxylic acid or ester group which may be reduced to a hydroxymethyl group, which in turn can be converted to a cyanomethyl group by methods well known in the literature.
Compounds of formula (XX), where W is a substituted 3pyridinyl group, can be prepared from compounds of formula (XXI), where L is defined as for Scheme I, by reaction with compounds of formula (XXII), where W is a substituted 3pyridinyl group, under conditions generally used for the well known Ullmann synthesis. For example the compounds of formula (XXI) can be treated with the metal salt (preferably the sodium or potassium salt) of the compounds of formula (XXII), either neat or in a suitable solvent such as N,N-dimethylformamide or dimethylsulphoxide at 50 250"C, but preferably at 100-1800C, in the presence of a transition metal catalyst such as copper bronze or copper halides.
Compounds of general formula (XXI) can be prepared by standard methods in the chemical literature.
Compounds of formula (XX), where W is a substituted 4pyridinyl group, can be prepared by reaction of the metal salt (preferably the sodium or potassium salt) of compounds Of formula (XXIII) with compounds of formula (I), where X is a substituted 4-pyridinyl group, in a suitable solvent such as N,N-dimethylformamide or dimethylsulphoxide at 23- 200"C, but preferably at 50-1500C, and optionally in the presence of transition metal catalysts such as copper bronze or copper halides.
Compounds of formula (XX) may also be prepared from compounds of formula (XXV), where P is defined as a pyridine N-oxide linked to A through the 4-position. P may or may not be substituted by substituents as defined for W in compounds of formula (I). If P in compounds of formula (XXV) is substituted, then deoxygenation of the N-oxide by standard methods, for example with phosphorus trichoride, will give compounds of formula (XX) where W is substituted 4-pyridinyl.If P in compounds of formula (XXV) is substituted or unsubstituted, then the well known reaction of pyridine N-oxides with phosphoryl or thionyl halides can be used to give the compounds of formula (XX) containing an additional halogen atom in the 2- or 6-position, with concurrent loss of the N-oxide function, (see, for example, "The chemistry of the Heterocyclic Compounds: Pyridine and Its Derivatives", Ed. E Klingsberg, Part Two, p 121).
Compounds of formula (XXV) can be prepared by the reaction of the metal salt (preferably the sodium or potassium salt) of the compounds of formula (XXIII), with the compounds of formula (XXIV), wherein P and L are as defined above, in a suitable solvent such as N,N-dimethylformamide or dimethylsulphoxide, at 20-2000C but preferably at 50-150", optionally in the presence of a transition metal catalyst such as copper bronze or copper halides.
Compounds of formula (XXIII) can be prepared by standard methods in the chemical literature.
In further aspects, the invention provides processes as herein described for preparing the compounds of the invention and the intermediate chemicals of formulae (III) (V), (IX)-(XV), (XVII), (XIX), (XX), and (XXV) used therein.
The compounds are active fungicides, and may be used to control one or more of the following pathogens: Pyricularia oryzae on rice Puccinia recondita, Puccinia striiformis and other rusts on wheat, Puccinia hordei, Puccinia striiformis and other rusts on barley, and rusts on other hosts e.g. coffee, pears, apples, peanuts, vegetables and oranmental plants.
Erysiphe graminis (powdery mildew) on barley and wheat and other powdery mildews on various hosts such as Sphaerotheca macularis on hops Sphaerotheca fuliginea on cucurbits (e.g. cucumber), Podosphaera leucotricha on apples and Uncinula necator on vines.
Helminthosporium spp., Rhynchosporium spp., Septoria spp., Pseudocercosporella herpotrichoides and Gaeumannomyces graminis on cereals.
Cercospora arachidicola and Cercosporidium personata on peanuts and other Cercospora species on other hosts for example sugar beet, bananas, soya beans and rice.
Botrytis cinerea (grey mould) on tomatoes, strawberries, vegetables, vines and other hosts.
Alternaria species on vegetables (e.g. cucumber), oil seed rape, apples, tomatoes and other hosts.
Venturia inaequalis (scab) on apples Plasmopara viticola on vines.
Other downy mildews such as Bremia lactucae on lettuce, Peronospora spp. on soybeans, tobacco, onions and other hosts and Pseudoperonospora humuli on hops and Pseudoperonospora cubensis on cucurbits Phytophthora infestans on potatoes and tomatoes and other Phytophthora spp. on vegetables, strawberries, avocado, pepper, ornamentals, tobacco, cocoa and other hosts.
Thanatephorus cucumeris on rice and other Rhizoctonia species on various host such as wheat and barley, vegetables, cotton and turf.
Some of the compounds have also shown a broad range of activities against fungi in vitro. They may have activity against various post-harvest diseases of fruit (e.g. Penicillium digitatum and italicum and Trichoderma viride on oranges and Gloesporiurn nusarum on bananas).
Further some of the compounds may be active as seed dressings against Fusarium spp., Septoria spp., Tilletia spp., (bunt, a seed borne disease of wheat), Ustilago spp., Helminthosporium spp. on cereals, Rhizoctonia solani on cotton and Pyricularia oryzae on rice.
The compounds can move acropetally in the plant tissue. Moreover, they may be volatile enough to be active in the vapour phase against fungi on the plant.
Therefore in another aspect of the invention there is provided a method of combating fungi, which comprises applying to a plant, to seed of a plant, or to the locus of the plant or seed, an effective amount of a fungicidal compound of formula (I).
The compounds may also be useful as industrial (as opposed to agricultural) fungicides, e.g. in the prevention of fungal attack on wood, hides, leather and especia.lly paint films.
Some of the compounds of the invention exhibit insecticidal and nematocidal activity.
Therefore in a further aspect of the invention there is provided a method of killing or controlling insect or nematode pests which comprises administering to the pest or to the locus thereof an effective amount of an insecticidal/nematocidal compound of formula (I).
A preferred group of compounds for use in this aspect of the invention are compounds of formula (I) where X is substituted pyridinyl wherein the substituents are preferably selected from halogen or haloalkyl.
Particularly preferred compounds for use in this method are compounds 14 and 15 in Table I.
Similarly, some compounds exhibit plant growth regulating activity and may be deployed for this purpose at appropriate rates of application. Therefore in yet a further aspect of the invention there is provided a method of regulating plant growth which comprises applying to a plant an effective amount of a plant growth regulating compound of formula (I).
The compounds may be used directly for agricultural purposes but are more conveniently formulated into compositions using a carrier or diluent. Therefore in yet a further aspect of the invention there are provided fungicidal, insecticidal/nematocidal and plant growth regulator compositions comprising a compound of general formula (I) as hereinbefore defined, and an acceptable carrier or diluent therefor.
As fungicides the compounds can be applied in a number of ways. For example they can be applied, formulated,or unformulated, directly to the foliage of a plant, to seeds or to other medium in which plants are growing or are to be planted, or they can be sprayed on, dusted on or applied as a cream or paste formulation, or they can be applied as a vapour or as slow release granules. Application can be to any part of the plant including the foliage, stems, branches or roots, or to soil surrounding the roots, or to the seed before it is planted- or to the soil generally, to paddy water or to hydroponics culture systems. The invention compounds may also be injected into plants or sprayed onto vegetation using electrodynamic spraying techniques or other low volume me zd s .
The term "plant" as used herein includes seedlings, bushes and trees. Furthermore, the fungicidal method of the invention includes preventative, protectant, prophylactic and eradicant treatment.
The compounds are preferably used for agricultural and horticultural purposes in the form of a composition. The type of composition used in any instance will depend upon the particular purpose envisaged.
The compositions may be in the form of dustable powders or granules comprising the active ingredient (invention compound) and a solid diluent or carrier, for example fillers such as kaolin, bentonite, kieselguhr, dolomite, calcium carbonate, talc, powdered magnesia, Fuller S earth, gypsum, diatomaceous earth and China clay.
Such granules can be preformed granules suitable for application to the soil without further treatment. These granules can be made either by impregnating pellets of filler with the active ingredient or by pelleting a mixture of the active ingredient and powdered filler. Compositions for dressing seed may include an agent (for example a mineral oil) for assisting the adhesion of the composition to the seed; alternatively the active ingredient can be formulated for seed dressing purposes using an organic solvent (for example N-methylpyrrolidone, propylene glycol or dimethylformamide). The compositions may also be in the form of wettable powders or water dispersible granules comprising wetting or dispersing agents to facilitate the dispersion in liquids. The powders and granules may also contain fillers and suspending agents.
Emulsifiable concentrates or emulsions may be prepared by dissolving the active ingredient in an organic solvent optionally containing a wetting or emulsifying agent and then adding the mixture to water which may also contain a wetting or emulsifying agent. Suitable organic solvents are aromatic solvents such as alkylbenzenes and alkylnaphthalenes, ketones such as isophorone, cyclohexanone, and methylcyclohexanone, chlorinated hydrocarbons such as benzyl alcohol, chlorobenzene and trichiorethane, and alcohols such as furfuryl alcohol, butanol and glycol ethers.
Suspension concentrates of largely insoluble solids may be prepared by ball or bead milling with a dispersing agent and including a suspending agent to stop the solid settling.
Compositions to be used as sprays may be in the form of aerosols wherein the formulation is held in a container under pressure in the presence of a propellant, eg.
fluorotrichloromethane or dichlorodifluoromethane.
The invention compounds can be mixed in the dry state with a pyrotechnic mixture to form a compos1ton suitable for generating in enclose spaces a smoke containing the compounds.
Alternatively, the compounds may be used in a microencapsulated form. They may also be formulated in biodegradable polymeric formulations to obtain a slow, controlled release of the active substance.
By including suitable additives, for example additives for improving the distribution, adhesive power and resistance to rain on treated surfaces, the different compositions can be better adapted for various utilities.
The invention compounds can be used as fixtures with fertilisers (eg. nitrogen-, potassium- or phosphoruscontaining fertilisers). Compositions comprising only granules of fertiliser incorporating, for example coated with, te compound are preferred. Such granules suitably contain up to 25% by weight of the compound. The invention therefore also provides a fertiliser composition comprising a fertiliser and the compound of general formula (I) or a salt or metal complex thereof.
Wettable powders, emulsifiable concentrates and suspension concentrates will normally contain surfactants eg. a wetting agent, dispersing agent, emulsifying agent or suspending agent. These agents can be cationic, anion' or non-ionic agents.
Suitable cationic agents are quaternary ammonium compounds, for example cetyltrimethylammonium bromide.
Suitable anionic agents are soaps, salts of aliphatic monoesters of sulphuric acid (for example sodium lauryl sulphate), and salts of sulphonated aromatic compounds (for example sodium dodecylbenzenesulphonate, sodium, calcium or ammonium lignosulphonate, butylnaphthalene sulphonate, ar a mixture of sodium diisopropyl- and triisoprspyl- naphthalene sulphonates).
Suitable non-ionic agents are the condensation products of ethylene oxide with fatty alcohols such as oleyl or cetyl alcohol, or with alkyl phenols such as octyl- or nonyl-phenol and octylcresol. Other non-ionic agents are the partial esters derived from long chain fatty acids and hexitol anhydrides, the condensation products of the said partial esters with ethylene oxide, and the lecithins. Suitable suspending agents are hydrophilic colloids (for example polyvinylpyrrolidone and sodium carboxymethylcellulose), and swelling clays such as bentonite or attapulgite.
Compositions for use as aqueous dispersions or emulsions are generally supplied in the form of a concentrate containing a high proportion of the active ingredient, the concentrate being diluted with water before use. These concentrates should preferably be able to withstand storage for prolonged periods and after such storage be capable of dilution with water in order to form aqueous preparations which remain homogeneous for a sufficient time to enable them to be applied by conventional spray equipment. The concentrates may conveniently contain up to 95%, suitably 10-85%, for example 25-60%, by weight of the active ingredient. After dilution to form aqueous preparations, such preparations may contain varying amounts of the active ingredient depending upon the intended purpose, but an aqueous preparation containing 0.0005% or 0.01% to 10% by weight of active ingredient may be used.
The compositions of this invention may contain other compounds having biological activity, eg. compounds having similar or complementary fungicidal activity or which plant possess plant growth regulating, herbicidal or insecticidal activity.
A fungicidal compound which may be present in the pomposition of the invention may be one which is capable of combating ear diseases of cereals (eg. wheat) such as Septoria, Gibberella and Helminthosporium spp., seed and soil borne diseases and downy and powdery mildews on grapes and powdery mildew and scab on apple etc. By including another fungicide, the composition can have a broader spectrum of activity than the compound of general formula (I) alone. Further the other fungicide can have a synergistic effect on the fungicidal activity of the compound of general formula (I).Examples of fungicidal compounds which may be included in the composition of the invention are carbendazim, benomyl, thiophanate-methyl, thlabendazole, fuberidazole, etridazole, dichlofluanid, cymoxanil, oxadixyl, ofurace, metalaxyl, furalaxyl, 4-chloro-N- (l-cyano-l-ethoxymethyl )benzamide, benalaxyl, fosetylaluminium, fenarimol, iprodione, prothiocarb, procymidone, vinclozolin, penconazole, myclobutanil, propamocarb, R0151297, diconazole, pyrazophos, ethirimol, iitalimfos, buthiobate, tridemorph, triforine, nuarimol, triazbutyl, guazatine, triacetate salt of l,l'-iminodi- (oc=amethylene)diguanidine, propiconazole, prochloraz, -lu.ria ol, hexaconazole, (2 RS, 3 RS)-2-(4-chlorophenyl) 3-cyclopropyl-l-(lH-l,2,4-triazol-l-yl)butan-2-ol, (RS)-1 (*-chloro-phenyl)-4,4-dimethyl-3-(lH-1,2,4-triazol-1- ylmethyl)pentan-3-ol, flusilazole, triadimefon, triadimenol, diclobutrazol, fenpropimorph, pyrifenox, fenpropidin, chlorozolinate, imazalil, fenfuram, carboxin, oxycarboxin, methfuroxam, dodemorph, BAS 454, blasticidin S, '.;;asugamycin, edifenphos, Kitazin P, cycloheximide, phthalide, probenazole, isoprothiolane, tricyclazole, pyroquilon, chlorbenzthiazone, neoasozin, polyoxin D, validamycin A, mepronil, flutolanil, pencycuron, diclomezine, phenazin oxide, nickel dimethyldithiocarbamate, techlofthalam, oltertanol, bupirimate, etaconazole, hydroxyisoxazole, streptomyci, cyprofuram, biloxazol, cuinomethionate, dimethirimol, i-(2- cyano-2-methoxyiminoacetyl)-3-ethyl urea, fenapanil.
tolclofos-methyl, pyroxyfur, polyram, maneb, mancozeb, captafol, chlorothalonil, anilazine, thiram, captan, folpet, zineb, propineb, sulphur, dinocap, dichlone, chloroneb, binapacryl, nitrothal-isopropyl, dodine, dithianon, fentin hydroxide, fentin acetate, tecnazene, quintozene, dicloran, copper containing compounds such as copper oxychloride, copper sulphate and Bordeaux mixture, and organomercury compounds.
The compounds of general formula (I) can be mixed with soil, peat or other rooting media for the protection of plants against seed-borne, soil-borne or foliar fungal diseases.
Suitable insecticides which may be incorporated in the composition of the invention include pirimicarb, dimethoate, demeton-s-methyl, formothion, carbaryl, isoprocarb, XMC, BPMC, carbofuran, carbosulfan, diazinon, fenthion, fenitrothion, phenthoate, cnlorpyrifos, isoxathion, propaphos, monocrotophas, buprofezin, ethroproxyfen and cycloprothrin.
Plant growth regulating compounds are compounds which control weeds or seedhead formation, or selectively control the growth of less desirable plants (eg. grasses).
Examples of suitable plant growth regulating compounds for use with the invention compounds are the gibberellins (eg. GA3, GA4 or GA7), the auxins (eg.
indoleacetic acid, indolebutyric acid, naphthoxyacetic acid or naphthylacetic acid), the cytokinins (eg. kinetin, diphenylurea, benzimidazole, benzyladenine or benzylaminopurine), phenoxyacetic acids (eg. 2,4-D or MCPA), substituted benzoic acid (eg. triiodobenzoic acid), morphactins (eg. chlorfloroecol), maleic hydrazide, glyphosate, glyphosine, long chain fatty alcohols and acids, dikegulac, paclobutrazol, fluoridamid, mefluidide, substituted quaternary ammonium and phosphonium compounds (eg. chloromequat chlorphonium or mepiquatchloride), ethephon, carbetamide, methyl-3, 6- dichloroanisate, daminozide, asulam, abscisic acid, isopyrimol, 1-(4-chlorophenyl)-4,-dimethyl-2-oxo-1,2-dihydropyridine- 3-carboxylic acid, hydroxybenzonitriles (eg. bromoxynil), difenzoquat, benzoylprop-ethyl 3,6-dichloropicolinic acid, fenpentezol, inabenfide, triapenthenol and tecnazene.
The following Examples illustrate the invention.
Throughout these Examples, the term 'ether' refers to diethyl ether; chromatography was carried out using silica gel as the solid phase; magnesium sulphate was used to dry solutions; and reactions involving water- or air-sensitive intermediates were performed under nitrogen and in dried solvents. where shown, infrared and NMR data are selective; no attempt is made to list every absorption.
Unless otherwise stated, NMK spectra were recorded using deuterochloroform solutions. The following abbreviations are used throughout = = gramme(s) delta = chemical shift mol = micromole(s) CDC13 = deuterochloroform ml = millilitre(s) s = singlet :rmHg = Millimetres pressure d = doublet of mercury t = triplet br = broad DMF = N,N-Dimethylformamide max. = maximum or maxima HPLC = High performance liquid chromatography mp. = Melting point ppm. = parts per million NMR = Nuclear magnetic resonance EXAMPLE 1 This Example illustrates the preparation of (E)methyl 2-[2'-(5"-chloropyridin-2"-yloxy)phenyl]-3-methoxy acrylate (Compound No. 14 of Table I).
A solution of 2,5-dichloropyridine (7.70g, 52.03mmol), potassium carbonate (14.01g, lOl.:, nmol) and the disodium salt derived from o-hydroxyphenylacetic acid (10.20g, 52.58mol) in dimethylsulphoxide (50ml) was stirred overnight at 160 C under an atmosphere of nitrogen.
The dark reaction mixture was poured into water (lOOmi), and extracted with ether (3 x 75ml). The aqueous phase was acidified to pH 6 with concentrated hydrochloric acid and then extracted with ethyl acetate (3 x 1001). The combined organic layers were washed with brine ' '2 x lOOml), dried and then evaporated under reduced pressure to give [2-(5'-chloropyridin-2'-yloxy)phenyl]acetic acid (5.30g) as a dark brown liquid (infrared max. 3500-2700, 1700, 1370, 1440, 750 cm-1) which was used without further purification. 2-(5'-Chloropyridin-2'-yloxy)phenylacetic acid (5.20g, 19.73mmol), potassium carbonate (5.53g, 40mmol) and dimethyl sulphate (2.91g, 23.07mmol) were stirred together overnight at room temperature in DMF (50ml). The reaction mixture was poured into water (100ml) and extracted with ethyl acetate (2 x 75ml) and ether (1 x 100ml). The combined organic layers were washed with water (3 x 75ml) and brine (2 x 100ml), and then dried and evaporated under reduced pressure to give methyl 2-(5'chloropyridin-2'-yloxy)phenylacetate (4.18g) as a dark brown liquid which was distilled at 152 C/0.1mmHg.
To a stirred suspension of sodium hydride (0.78g, 50% dispersion in oil) in DMF (40ml) at -250C was added dropwise a solution of methyl 2-(5'-chloropyridin-2'yloxy)phenylacetate (2. 90g, 10.45mmol) and methyl formate (14.88g, excess) in DMF. The reaction mixture was partitioned between saturated podium carbonate solution ether. The aqueous layer was acidified with concentrated hydrochloric acid to pH 4-5 (yellow precipitate) and then extracted with ethyl acetate (3 x 100ml). The organic extracts were combined, dried and evaporated under reduced pressure to give methyl 2-[2'-(5"-chloropyridin-2"- yloxy)phenyl]-3-hydroxyacrylate as an orange-red solid (2.36g).The solid (2.30g, 7.54mmol) was stirred overnight in DMF (50ml) at room temperature with dimethyl sulphate (1.21g, 9.59mmol) and potassium carbonate (2.44g, 17.6mmol). The reaction mixture was poured into water (looms) and then extracted with ethyl acetate (3 x l00ml).
The combined organic layers were washed with water (3 x 75ml) and brine (2 x l00ml), and then dried and evaporated under reduced pressure to give a brown viscous liquid.
HPLC (eluent ether - petroleum ether 50:50) gave a pale yellow liquid which crystallised on standing (2.14g).
Recrystallisation from methanol gave (E)-methyl 2-E2'-(5"- chloropyridin-2"-yloxy)phenyl]-3-methoxyacrylate, m.p.
77-B0C; infrared max. 1700, 1625, 1260, 1200 cm'l; 1H NMR delta (CDCl3) 3.57 (3H,s), 3.74 (3H,s), 6.75 (lH,d), 7.41 (1H,s), 8.10 (lH,brs), 7.1-7.6 (m) ppm.
EXAMPLE 2 This Example illustrates the preparation of (E)methyl-2-[2',d"-cyanopyridin-2"-yloxy)phenyl]-3methoxyacrylate (Compound No. 127 of Table I).
Ortho-hydroxyphenylacetic acid (3.08g; 0.02 mol) was added to a stirred solution of potassium hydroxide (2.26g, 0.04 r..ol) in methanol (40 ml). After 15 minutes the solution was evaporated to dryness under reduced pressure and the solid residue slurried in DMF (50 ml).
6-Chloronicotinonitrile (3.08g; 0.022 mol) and copper bronze (0.lg) was added and the mixture stirred at aO- 90 C for 1 hour, then cooled and drowned into water (200 ml). The mixture was filtered and the pH of the filtrate was adjusted to 2-3 by addition of hydrochloric acid. The mixture was extracted with ether (x3). The combined ether extracts were extracted with saturated sodium bicarbonate solution. The aqueous phase was acidified with hydrochloric acid (pH 2-3) to produce a tarry solid.
Trituration wit a little methanol gave a white solid (1.27g, 25% yield). Recrystallisation from water afforded 2-[2'-(5"-cyanopyridin-2"-yloxy)phenyl]acetic acid as a white solid mp. 120 C. Infrared max. 1672 cm-1; 1H NMR (d6 DMSO; 60MHz) delta 3.45 (2H,s); 7.05-7.45 (5H,m): .25- 8.35 (m,lH); 8.6 (lH,d); 6.3 (brs,lH) ppm.
The acid (3.0g, 0.0118 mol) was stirred at reflux in methanol (50 ml) containing concentrated sulphuric acid (0.1 ml) for 3 hours. The mixture was cooled, water (200 ml) was added and the mixture was extracted with ether (3 x 50 ml). The combined ether extracts were washed with saturated sodium bicarbonate solution (30 ml), water (3 x 30 ml) and saturated brine (1 x 30 ml). After rylng and filtration the ether solution was evaporated to yield methyl 2-[2'-(5"-cyanopyridin-2"-yloxy)phenyl]acetate as an amber oil (2.77g, 87.5% yield); infrared max. (thin film) 2200, 1700 cm 1; 1H NMR (CDCl3) 3.5 (5H,s); 6.8-7.3 (5H,m): 7.8 (lH,q); 8.3 (lH,d) ppm.
Trimethylsilyl trifluoromethylsulphonate (1. 42g; 0.0064 mol) was added dropwise to a solution of triethylamine (0.65g; 0.0064 mol) in diethyl ether (10 ml) at room temperature. The mixture was allowed to stand for 20 minutes then added dropwise over 15 minutes to a stirred solution of methyl 2-[2'-(5"-cyanopyridyloxy)phenyl]acetate (1.15g; 0.0043 moles) in ether (10 ml) at 0-5 C. The mixture was allowed to warm to room temperature and stirred for an hour to yield a two phase mixture. The upper layer (solution A) was retained.
Meanwhile, titanium tetrachloride (1.22g, 0.0064 mol) was added dropwise to a stirred solution of trimethyl orthoformate. 71g; 0.0064 mol) in dichloromethane (lOml) at -70"C. The resulting yellow precipitate was stirred for 15 minutes and solution A was added dropwise over 20 minutes maintaining the temperature at -70 C. The mixture was stirred at -70 C for 1 hour then allowed to warm to room temperature and stirred for 1 hour. Saturated sodium carbonate solution (50 ml) was added and the mixture was filtered. The filtrate was extracted with ether (3 x 20 ml). The combined organic extracts were washed with water (3 x 15 ml), saturated brine (15 ml) and after drying and filtration the ether solution was evaporated to dryness under reduced pressure.Chromatography of the residue (hexane/ether) gave the title compound as a glass which on trituration with methanol gave white crystals (*D mg, 3% yield) mp. 108.5-109.5 C; 1H NMR delta 3.58 (3H,s); 3.75 (3H,s); 6.9 (1H,d); 7.1 (1H,d); 7.28-7.4 (4H, m). 7.45 (lH,s); 7.85 (lH,q), 8.45 (lH,d) ppm.
EXAMPLE 3 This Example illustrates the preparation of (E)-methyl 2-[2'-(5"-nitropyridin-2"-yloxy)phenyl]-3-methoxyacrylate (Compound No. 133 of Table I).
2-'flydroxyphenyl)acetic acid (50g) was added to a solution of hydrogen chloride in methanol Eprepared from acetyl chloride (25 ml) and methanol (250 ml)]. The solution was stirred at room temperature for three hours and then allowed to stand overnight (fifteen hours). The resulting mixture was concentrated under reduced pressure, and the residue was taken up in ether (250ml) and washed with an aqueous solution of sodium bicarbonate until effervescence ceased.The ethereal solution was dried and then concentrated under reduced pressure and the resulting solid was recrystallized from ether/petrol to afford methyl (2-hydroxyphenyl)acetate (50g; 92% yield) as white, powdery crystals, mp. 70-72 C; infrared max. (nujol mull): 3420, 1715 cm1; 1H nmr (90 MHz): delta 3.70 (2H,s), 3.75 (3H,s), 6.80-6.95 (2H,m), 7.05-7.10 (lH,m), 7.15-7.25 (1H, m), 7.40 (1H, s) ppm.
Methyl (2-hydroxyphenyl)acetate (21.0g) was dissolved in DMF (200ml), and potassium carbonate (19. 35g) was added in one portion. Benzyl bromide (23.94g) in DMF (50ml) was added dropwise to this mixture, with stirring, at room temperature. After eighteen hours the mixture was poured into water (500mol) and extracted with ether (2 x 400ml).
The extracts were washed with water (3 x 150ml) and brine (100ml), dried and filtered through silica gel (50; Merck 60), then concentrated under reduced pressure to afford a yellow oil. Distillation at 160 C and 0.05 mmHg afforded methyl 2-benzyloxyphenylacetate as a clear, colourless oil (26.99g; 83% yield), infrared max. (film): 1730 cm-1; 1H nmr (90 MHz): delta 3.60 (3H,s), 3.75 (2H,s), 4.10 (2H,s), 6.80-7.40 (9H,m) ppm.
A mixture of methyl 2-benzyloxyphenylacetate (26. 99g) and methyl formate (126.62g) in dry DMF (300ml) was added dropwise to a stirred suspension of sodium hydride (50% disp. in oil, 10.13g) in DMF (300 ml) at 0CC. After stirring at 0 C for two hours the mixture was poured into water (1000ml) and washed with ether (2 x 150ml). The aqueous layer was acidified to pH4 with 6M hydrochloric acid then extracted with ether (2 x 350ml). The extracts were dried and concentrated under reduced pressure to afford crude methyl 2-[2'-benzyloxyphenyl]-3-hydroxy- acrylate as a yellow oil, infrared max. (film): 1720, 1660 cm-1.
The crude methyl 2-(2'-benzyloxyphenyl)-3-hydroxyacrylate was dissolved in dry DMF (100ml) and potassium carbonate (29.0g) was added in one portion. Dimethyl sulphate (16.00g) in dry DMF (13ml) was then added dropwise with stirring. After ninety minutes, water (300ml) was added and the solution was extracted with ether (2 x 300ml). After washing with water (3 x 150ml) and brine, the extracts were dried and concentrated under reduced pressure, and the resulting yellow oil solidified on trituration with ether/petrol.Recrystallization from dry methanol afforded (E)-methyl 2-(2 '-benzyloxyphenyl)-3- methoxyacrylate as a white, crystalline solid (5.44g, 17% yield from methyl 2-benzyloxyphenylacetate), mp. 76-77 C; infrared max. (nujol mull): 1710, 1640 cm 1; 1H nmr (90 MHz): delta 3.63 (3H,s), 3.75 (3H,s), 5.05 (2H, s), 6.80-7.40 (9H, m), 7.50 (1H, s) ppm.
(E)-Methyl 2-(2 '-benzyloxyphenyl)-3-methoxyacrylate (5.44g) was dissolved in ethyl acetate (50ml) and 5% palladium on carbon (0.25g) was added. The stirred mixture was hydrogenated at three atmospheres pressure, with stirring, until no more hydrogen was taken up, then filtered through celite and silica gel (50g, Merck 60).
Concentration of the filtrate under reduced pressure afforded (E)-methyl 2-(2'-hydroxyphenyl)-3-methoxyacrylate as a white crystalline solid (3.76g; 99% yield), mp. 125126 C; infrared max. (nujol mull): 3400, 1670 cm-1; 1H NMK (270 MHz): delta 3.80 (3H,s), 3.90 (3H,s), 6.20 (1H,s), 6.80-7.00 (2H,m), 7.10-7.30 (2H,m), 7.60 (1H, s)ppm.
(E)-Methyl 2-(2'-hydroxyphenyl)-3-methoxyacrylate (0.30g, 1.44 mmol), 2-chloro-5-nitropyridine (0.46g, 2. 88 sumol ) and potassium carbonate (0.40g, 2.38 m.ur.ol were stirred together in DMF (20 ml) at room temperature under an atmosphere of nitrogen. After 18 hours, the reaction mixture was poured into water and then extracted twice with ether. The combined ether layers were washed twice with water and brine, and then dried. The resultant solution was filtered through a plug of silica gel and then concentrated to afford a pink solid.Chromatography (eluent-ether) afforded (E)-methyl 2-E2 '-(5"-nitropyridin- 2"-yloxy)phenyol]-3-methoxyacrylate (240 mg) as a yellow gum which crystallised on standing, m.p. 107-109 C; 1H NMR: As Table IV.
EXAMPLE 4 This Example illustrates the preparation of (E)-methyl 2-[2'-(4"-chloropyrimidin-2"-yloxy)phenyl]-3methoxyacrylate (Compound No. 61 of Table I).
#-Methyl 2-(2'-hydroxyphenyl)-3-methoxyacrylate (0.63g), 2,4-dichloropyrimidine (0.75g) and potassium carbonate (0.69g) were stirred together in DMF at room temperature. After 2 hours the reaction mixture was poured into water (50 ml) and extracted twice with ether. The combined ether layers were washed with water (x3) and brine (xl) and then dried. Filtration and evaporation of the solvent under reduced pressure afforded a clear oil.
Chromatography (eluent-ether) gave (E)-methyl 2-C2'-(4" chloro-pyrimidin-2"-yloxy)phenyl]-3-methoxyacrylate (0. 35g) as an oil which crystallised on trituration with ether, m.p. 120-121.5 C; 1H NMR delta 3.60 (3H,s); 3.80 (3H,s); 6.60 (lH,d,J-4Hz); 7.40 (lH,s); 8.40 (lH,d,J-4Hz) ppm.
EXAMPLE 5 This Example illustrates the preparation of (E)-methyl 2-[2'-(5'-chloropyridin-2"-ylthio)phenyl]-3-methoxyacrylate (Compound No. 14 of Table II).
To a mixture of the disodium salt of omercaptophenylacetic acid (formed by treatment of omercaptophenylacetic acid (1.68g) with sodium hydroxide (0.8g) in methanol (10 ml) followed by evaporation of half of the resultant solution to dryness and re-dissolution in 10 ml of DMF) and copper-bronze was added a solution of2,5dichloropyridine in DNF (5 ml). The reaction mixture was heated to 110-120"C for 90 minutes, added to water, acidified, and then extracted (x3) with ether. The combined ether layers were extracted with 2N sodium hydroxide (xl) and the resultant orange aqueous phase was acidified with dilute hydrochloric acid.The resulting suspension was filtered, and the solid was thoroughly washed with water and dried to give E2'-(5"-chloropyridin- 2"-ylthio)phenyl]-acetic acid (0.88g) as a fawn-coloured solid, m.p. 141-4"C.
2 '-(5"-Chloropyridin-2"-ylthio)phenylzacetic acid :.5) was heated to reflux in methanol (15 ml) containing two drops of concentrated sulphuric acid. After 40 minutes, the solution was cooled to room temperature, poured into water and then extracted (x2) with ether. The combined organic phases were washed with 1M sodium hydroxide solution and water (x3) and then dried.
Concentration under reduced pressure afforded methyl [2' -(5"-chloropyridin-2"-ylthio)phenyl]-acetate (610 mg) as a brown oil which was used without further purification.
To a stirred suspension of hexane-washed sodium hydrie (0.144g, 50% dispersion in oil) in DMF cooled to 2"C (ice/salt bath) was added a solution containing methyl [2 '-(5"-chloropyridin-2"-ylthio)phenyl]acetate (0.44g) and methyl formate (1.8g) in DMF (10 ml). The resultant reaction mixture was allowed to warm to room temperature.
After 4 1/2 hours, the reaction was quenched by careful addition of water, acidified with dilute hydrochloric acid, and then extracted (x3) with ether. The orange organic layers were combined, washed with water and then dried.
Concentration under reduced pressure gave a crude mixture containing methyl 2-[2 -(5"-chloropyridin-2"- ylthio)phenyl]-3-hydroxyacrylate (0.40g) as an orange gum (infrared max. 1665 cm 1) which was used directly in the next stage. The orange gum was dissolved in DMF (10 ml) and potassium carbonate was added. The resulting suspension was cooled to 0 C and then a solution of dimethyl sulphate in DMF (2 ml) was added dropwise over 5 minutes. After stirring at 00C for 1 hour, the reaction mixture was warmed to room temperature, poured into water and then extracted (x4) with ethyl acetate. The combined organic phases were washed with water (x2) and then dried.
Concentration under reduced pressure afforded a red oil (0.46g) which was chromatographed (eluent-ether-hexane 1:1) to give the title compound (0.085g) as a thick gum, infrared max. 1700, 1630 cm-1, 1H NMR : As Table IV.
EXAMPLE 6 This Example illustrates the preparation of (E)-methyl 2-[2'-(5"-bromopyridin-2"-ylthio)phenyl]-3-methoxyacrylate (Compound No. 15 of Table II), (E)-methyl 2-(2'-(5"-bromopyridin-2"-ylsulphinyl)phenyl]-3-methoxyacrylate (compound No. 1 of Table III) and (E)-methyl 2-(2'-(5"-bromopyridin2"-ylsulphonyl)phenyl]-3-methoxyacrylate (compound No. 2 of Table III).
(E)-Methyl 2- C 2 ' - ( 5 " -bromopyr idin-2 " -ylthio ) phenyl -3 - methoxyacrylate (200 mg) prepared from 2,5-dibromopyridine following the procedure outlined in Example 5) was treated with meta-chloroperbenzoic acid (113 mg) in dry dichloromethane (10 ml) at 0 C. The orange solution became colourless within 15 minutes. After stirring for 30 minutes, the reaction mixture was partitioned with aqueous sodium hydrogen carbonate solution. The organic layer was washed with a second portion of aqueous sodium hydrogen carbonate solution and then with water and dried.The solvent was removed under reduced pressure to give a yellow gum (O. 14g) which was chromatographed (eluent ether) to afford (E)-methyl 2-C2'-(5"-bromopyrid-2"- ylsulphinyl)phenyl]-3-methoxyacrylate as a gum (30 mg); 1E NMR as Table IV; and (E)-methyl 2-(2'-(5"-bromopyrid-2"- ylsulphonyl)phenyl[-3-methoxyacrylate as an amorphous s; (30 mg); 1H NMR as Table IV.
EXAMPLE 7 This Example illustrates the preparation of (E)methyl 2-[2'-5"-methoxycarbonylpyridin-2"-yloxy)phenyl]-3methoxyacrylate (Compound No. 141 of Table I).
Methyl 2-[2'-5'-cyanopyridin-2"-yloxy)phenyl]acetic (2.03g 0.008 mol; prepared as described in Example 2) was heated at reflux in a solution of potassium hydroxide (l.Og; 0.017 mol) in water (30 ml) for 16 hours. The solution was cooled to room temperature and the pH was adjusted to 2-3 by the addition of hydrochloric acid. The resulting precipitate was filtered, washed with a little ice-cold water and dried at 95 C (1.83g).
Recrystallisation from aqueous methanol afforded 2-[2'-(5- carboxypyridin-2"-yloxy)phenyl]acetic acid (1.83g) as white crystals; mp. 187-188 C; infrared max 3400, 256, 1710, 1686 cm-1; 1H NMR (d6 DMSO) delta 3.42 (2H, s); 6.32 (lH,brs); 6.95-7.44 (5H, m); 8.1 (lH,brs); 8.27 (lH,q); 3.62 (lH,d) ppm.
A mixture of 2 - r 2 ' (5"-carboxypyrid-2"-yloxy)phenyl] acetic acid (1.46g; 0.0053 mol), methyl iodide (1.52g, 0.00107 mol), potassium carbonate (2.95g; 0.021 mol) and DMF was stirred at room temperature for 3 hours. The mixture was drowned into water (100 ml) and extracted wit ether (2 x 40 ml). The combined organic extract was washed with water (3 x 20 ml), and saturated brine (20 ml). After drying the filtration, evaporation of the ether solution gave methyl 2-[2'-(5"-methoxycarbonylpyridin-2"yloxy)phenyl] acetate as an oil (0.73g) 1H NMR delta 3.45 (3H,s); 3.47 (2H,s); 3.79 (3H,s); 6.73-7.3 (5H,m); 8.2 (lH,q); 8.7 (lH,d) ppm.
Trimethylsilyl trifluoromethanesulphonate (0.81g; 0.0036 molar) was added dropwise to a solution of triethylamine (0.37g, 0.0036 mol) in ether (10 ml) at room temperature. After standing for 20 minutes the resulting solution was added dropwise to a solution of methyl 2-r2 (5-methoxycarbonyl)pyridin-2"-yloxy)phenyl]acetic in ether (10 ml) at 0-5 C over 20 minutes. The mixture was allowed to stir and warm to room temperature over 3 hours. The upper clear layer from this mixture was retained (solution Meanwhile in a separate flask a solution of titanium tetrachloride (0.69g, 0.0036 mol) in dichloromethane (5 ml) was added to a solution of trimethylorthoformate (O.4g; 0.0036 mol) in dichloromethane (10 ml) at -700C. The resulting yellow precipitate was stirred at -700C for 15 minutes. Solution A was added to the mixture dropwise over 10 minutes, maintaining the temperature at -70 C. The mixture was stirred for 1 hour, left to stand for 16 hours.
Saturated sodium carbonate solution (50 ml) was added and the mixture was filtered. The filtrate was extracted wit ether (3 x 20 ml) and the combined organic extracts were washed with water (3 x 15 ml) and saturated brine (15 ml).
After trying and filtration the ether solution was evaporated to leave a tarry residue. The title compound was isolated as an oil from the residue by chromatography (eluent-hexane) (20 mg).
NMR delta 3.47 (3H,s); 3.62 (3H,s); 3.82 (3H,s); 6,75- 7.3 (5H, m); 7.32 (lH,s); 8.15 (lH,q); 8.72 (l'.i,d) ppm.
EXAMPLE 8 This Example illustrates the preparation of (E )-methyl 2-[2'-(5"-benzyloxycarbonylpyridin-2"-yloxy)phenyl]-3 methoxyacrylate (Compound No. 184 of Table I).
2-[2'-(5"-Carboxypyrid-2"-yloxy)phenyl]acetic acid (1.5g; 0.005 molar; prepared as described in Example 7) was heated with methanol (50 ml) and sulphuric acid (0.1 ml) under reflux for 8 hours. The mixture was reduced to half bulk by evaporation, cooled, drowned into water (100 ml) and then extracted with ether (2 x 30 ml). The combined organic extracts were extracted with saturated sodium bicarbonate solution. The alkaline extract was acidified with hydrochloric acid to pH 2.3, cooled in ice-water and the resulting white precipitate was filtered, washed with water and dried at 95 C to afford methyl 2-[2'-(5"-carboxypyridin-2"-yloxy)phenyl] acetate (0.63g); mp. 118 C; 1H NMR delta 3.52 (3H,s); 3.57 (2H,s); 6.88-7.4 (5H,m); 8.3 (lH,q); 8.88 (lH,d) ppm.
A mixture of methyl-2-[2'-(5"-carboxypyridin-2"yloxy)phenyl]acetic (0.63g; 0.0022 ml), benzyl bromide (0.37g, 0.0021 moles), potassium carbonate (0.6g; 0.0043 moles) and DMF (30 ml) was stirred at room temperature for 1 hour. The mixture was drowned into water (100 ml) and extracted with ether (2 x 30 ml). The combined organic extract was washed with water (3 x 15 ml) and saturated brine (15 ml). After drying and filtration, the ether solution was evaporated to give methyl 2-[2'-(5"- benzyloxycarbonylpyridin-2"-yloxy)phenyl]acetate as a colourless gum which was purified by chromatography (eluent/hexane) to give a colourless solid (0.69g); mp.
56 C; infrared max 1735, 1722 cm-1, lp NMR delta 3.44 (3H,s); 3.5 (2H,s); 5.24 (2H,s); 6.76-7.4 (5H,m); 8.2 (lH,q); 8.76 (lH,d) ppm.
Trimethylsilyl trifluoromethylsulphonate (0.61g, .0027 moles) was added dropwise at room-temperature to a solution of triethylamine (0.277g; 0.0027 moles) in ether (5 ml). The mixture was allowed to stand for 20 minutes and the resulting solution was added to a stirred mixture of methyl 2-[2'-(5"-benzyloxycarbonylpyridin-2"-yloxy) phenyl zacetate in ether (5 ml) at 0-5"C over 15 minutes.
The resulting mixture was allowed to stir and warm to room temperature over 3 hours then diluted with dichloromethane (D ml) and retained (solution A).
Meanwhile a solution of titanium tetrachloride (0.52g, 0.0027 moles) in dichloromethane (2 ml) was added dropwise to a solution of trimethylorthoformate (0.301g; 0.0-077 moles) at -700C. The resulting yellow precipitate was stirred at -700C for 15 minutes and solution A was added dropwise over 30 minutes, maintaining the temperature at -70 C. The mixture was stirred, allowed to warm to room temperature over 1 hour then left to stand for 15 hours.
Saturated sodium carbonate solution (30 m) was added and the mixture was stirred, then filtered. The filtrate was extracted with ether (3 x 15 ml). The combined ether extracts were washed with water (3 x 10 m) and saturated brine (10 ml). After drying and filtration the ether solution was evaporated to give a gum. The title compound was isolated by chromatography (eluent-hexane) as a gum; 19 NMR delta 3.55 (3H,s); 3.60 (3H,s); 5.35 (2H,s); 6.82 (lH,d); 7.18-7.48 (m, including a one proton singlet at 7.39); 8.25 (lH,q); 8.25 (lH,d) ppm.
EXAMPLE 9 This Example illustrates the preparation of (E)- methyl 2-E2 ' -(6"-methylpyridin-3"-yloxy)phenyl]-3-methOxy- acrylate (compound No. 45 of Table I).
6-Methyl-3-hydroxypyridine (9.5g) was suspended in toluene (30 ml) and treated with aqueous potassium hydroxide C4.9g in water (8 ml)]. The mixture was stirred vigorously for 15 minutes then evaporated under reduced pressure. Last traces of water were removed by repeated evaporation in the presence of toluene. The brown semisolid formed was treated with a combination of 2-(2-bromo henyl)-1,3-dioxolane (10.0g), cuprous chloride (60 mg) and tris [2-(2-methoxyethoxy)ethyl]amine (0.194g) to solubilise the copper salt, in dry DMF (25 ml) and the mixture was heated to 155 DC with stirring under nitrogen for 30 hours.
Further cuprous chloride (60 mg) was added and heating continued for 14 hours.
The mixture was cooled, poured into water and extracted with ethyl acetate. The extract was washed with 2N aqueous sodium hydroxide solution and water, followed by extraction with 2N hydrochloric acid. The acidic aqueous extract was treated with solid potassium carbonate until pH 8 and then extracted with ethyl acetate. This organic extract was dried and then evaporated under reduced pressure to give 2-(6 '-methylpyridin-3 '-yloxy)benzaldehyde (2.2g) as an oil; infrared maxima (film) 1697, 1606, 1480 cm 1; 1H NMR delta 2.58 (3H,s); 6.86 (1H,s); 7.28 (3H,m); 7.55 (lH,t); 7.95 (lH,m); 8.36 (lH,m); 10.53 (lH,s) ppm.
2-(6 '-Methylpyridin-3 '-yloxy)benzaldehyde (2.08g) and methyl methylsulphinylmethyl sulphide (1.21g) were dissolved in dry THF (15 ml) and Triton B (1.5 ml) was added slowly dropwise with stirring at room temperature.
The mixture was stood overnight, diluted with water and extracted with ethyl acetate. This extract was dried and then evaporated under reduced pressure, giving an orangebrown oil (3.2g). The oil was treated with a methanol solution of hydrogen chloride (25 ml, 2.6N) and stood overnight at room temperature. The solution was then diluted with water and brought to pH 8 by the addition of sodium carbonate.The mixture was extracted with ethyl acetate and the extract dried and evaporated to give a brown oil (2.23g) which was purified by HPLC (eluent 1:1, ethyl acetate : hexane) to give methyl C2-(6'- methylpyridin-3'-yloxy)phenyl]acetate, as a yellow oil (1.53g) infrared maxima (film) 1747, 1488, 1237 cm-1; 1H NMR delta 2.54 (3H,s): 3.63 (3H,s); 3.74 (2H,s); 6.84 (lH,d); 7.24 (5H,m); 8.3 (lH,d) ppm.
A mixture of methyl r2-(6'-methylpyridin-3'-yloxy)- phenyl]acetate (1.3g) and methyl formate (1.52g) in DMF (5 ml) was added dropwise to a suspension of sodium hydride (316 mg of 50% oil dispersion) in DMF (5 ml), with stirring at 5 C. After stirring for 4 hours the mixture was diluted with water, made weakly acidic by addition of glacial acetic acid (pH 4-5) and extracted with ethyl acetate. This extract on drying and evaporation under reduced pressure, gave methyl 2- 2 '-(6"-methylpyridin-3"- yloxy) phenyl]-3-hydroxyacrylate as a yellow oil (1.15g) 1H NMR delta 2.53 (3H,s); 3.63 (3H,s); 6.89 (lH,s); 7.2 (5H,m); 8.21 (lH,d) ppm.
The oil (1.14g) was dissolved in DMF (15 ml), potassium carbonate (1.1g) was added and the mixture stirred for 15 minutes. Dimethyl sulphate (O.53g) was dissolved in DMF (5 ml) and this solution added to the mixture. The resulting mixture was stirred for 30 minutes then diluted with water and the resulting emulsion extracted with ethyl acetate.This extract was dried and evaporated under reduced pressure to give a yellow oil (2.06g), which was purified by HPLC (eluent ethyl acetate), to give (E)-methyl 2-[2'-(6"-methylpyridin-3" yloxy)phenyl3-3-methoxyacrylate as a pale yellow oil (0.73g), infrared maxima (film) 1705, 1642, 1488 c-1; 1 NMR delta 2.52 (3H,s); 3.63 (3H,s); 3.81 (3H,s); 6.88 (lH,d), 7.04-7.32 (5H,m); 7.51 (lH,s); 8.26 (lH,d) ppm.
The following are examples of compositions suitable for agricultural and horticultural purposes which can be formulated from the compounds of the invention. Such compositions form another aspect of the invention.
EXAMPLE 10 An emulsifiable concentrate is made up by mixing and stirring the ingredients until all are dissolved.
Compound No. 61 of Table I 10% Benzyl alcohol 30% Calcium dodecylbenzenesulphonate 5% Nonylphenolethoxylate (13 moles ethylene oxide) 10% Alkyl benzenes 45% EXAMPLE 11 The active ingredient is dissolved in methylene dichloride and the resultant liquid sprayed on to the granules of attapulgite clay. The solvent is then allowed to evaporate to produce a granular composition.
Compound No. 14 of Table I 5% Attapulgite granules 95% EXAMPLE 12 A composition suitable for use as a seed dressing is prepared by grinding and mixing the three ingredients.
Compound No. 61 of Table I 50% Mineral oil 2% China clay 48% EXAMPLE 13 A dustable powder is prepared by grinding and mixing the active ingredient with talc.
Compound No. 61 of Table I 5% Talc 95% EXAMPLE 14 A suspension concentrate is prepared by ball milling the ingredients to form an aqueous suspension of the ground mixture with water.
Compound No. 61 of Table I 40% Sodium lignosulphonate 10% Bentonite clay 1% Water 49% This formulation can be used as a spray by diluting into water or applied directly to seed.
EXAMPLE 15 A wettable powder formulation is made by mixing together and grinding the ingredients until all are thoroughly mixed.
Compound No. 61 of Table I 25% Sodium lauryl sulphate 2% Sodium lignosulphonate 5% Silica 25% China clay 43% EXAMPLE 16 The compounds were tested against a variety of foliar fungal diseases of plants. The technique employed was as follows.
The plants were grown in John Innes Potting Compost (No 1 or 2) in 4cm diameter minipots. The test compounds were formulated either by bead milling with aqueous Dispersol T or as a solution in acetone or acetone/ethanol which was diluted to the required concentration immediately before use. For the foliage diseases, the formulations (100 ppm active ingredient) were sprayed onto the foliage and applied to the roots of the plants in the soil. The sprays were applied to maximum retention and the root drenches to a final concentration equivalent to approximately 40 ppm a.i./dry soil. Tween 20, to give a final concentration of 0.05%, was added when the sprays were applied to cereals.
For .most of the tests the compound was applied to the soil (roots) and to the foliage (by spraying) one or two days before the plant was inoculated with the disease. An exception was the test on Erysiphe graminis in which the plants were inoculated 24 hours before treatment. Foliar pathogens were applied by spray as spore suspensions onto the leaves of test plants. After inoculation, the plants were put into an appropriate environment to allow infection to proceed and then incubated until the disease was ready for assessment. The period between inoculation and assessment varied from four to fourteen days according to the disease and environment.
The disease control was recorded by the following grading 4 = no disease 3 = trace -5% of disease on untreated plants 2 = 6-25% of disease on untreated plants 1 = 26-59% of disease on untreated plants 0 = 60-100% of disease on untreated plants The results are shown in Table V.
TABLE V
COMPOUND TABLE PUCCINIA ERYSIPHE VENTURIA PYRICULARIA CERCOSPORA PLASMOPARA PHYTOPHIBORA NUMBER NO. RECONDITA GRAMINIS INAEQUALIS ORYZAE ARACHIDICOLA VITICOIA INEESTANS (WHEAT) HORDEI (APPLE) (RICE) (PEANUT) (VINE) (TOMATO) (BARLEY) 10 I 4 4 4 4 3 4 4 11 I 3* 4* 4* 2* 0* 4* 4* 14 I 4 4 2 4 4 4 15 I 4 4 - 3 3 4 16 I 2 4 4 4 4 4 4 21 I 3 4 4 4 4 4 3 22 I 4 4 4 4 4 4 3 61 I 3 4 4 0 4 1 0 67 I 3** 2** 0** 0** 4** 4** 0* 129 I 0 4 4 0 0 0 0 130 I 3 0 0 0 4 0 0 131 I 3 0 0 0 0 0 0 133 I 4 4 4 4 - 4 0 137 I 2 0 4 0 0 0 0 138 I 4 0 3 0 0 4 0 139 I 4 0 0 2 4 4 0 140 I 2 0 0 0 0 4 0 165 I 2 4 4 2 4 4 3 166 I 4 4 4 1 4 3 3 167 I 4 4 4 3 0 4 14 II 4 4 4 3 4 4 0 15 II 2 3 0 0 1 4 0 1 III 0* 0* 3* 0* 0* 0* 0* 2 III 3 0 3 0 0 0 0 * 25 ppm foliar spray only ** 40 ppm foliar spray only EXAMPLE 17 This Example illustrates the plant growth regulating properties of compounds 14-16, 22, 61, 132 and 138-140 of Table I.
These compounds were tested on a whole plant screen for plant growth regulating activity against six species of plant. The plant species used in this screen are presented in Table VI with the leaf stage at which they were sprayed.
A formulation of each chemical was applied at 4000 ppm '4 Xg/ha in a 1000 l/ha field volume) using a tracksprayer and a SS8004E (Teejet) nozzle. Additional tests were done on tomatoes at 2000 and 500 ppm.
After spraying, the plants were grown in n glasshouse with 25 C day/22 C night temperatures. The exceptions to tis ere the temperate cereals, wheat and barley which were grown in 13-16 C day/11-130C night temperatures.
Supplementary lighting was supplied when necessary to provide an average photoperiod of 16 hours (14 hours minimum).
After 2-6 weeks in the glasshouse, depending on species and time of year, the plants were visually assess - orphological characteristics against a control plant sprayed with a blank formulation. The results are presented in Table VII.
TABLE VI PLANT MATERIAL USED FOR WHOLE PLANT SCREEN
Species Code Variety Growth Stage No. Plants Compost at Treatment per 3" pot Type Barley BR Atem 1 - 1.5 leaves 4 JIP* Wheat WW Timmo 1 - 1.5 leaves 4 JIP Maize MZ Earliking 2 1/4 - 2 1/2 leaves 1 PEAT Apple AP Red Delicious 4 - 5 leaves 1 JIP Rice RC Ishikari 2 - 2 1/2 leaves 4 JIP Tomato TO ailsa Craig 2 - 2 1/2 leaves 1 PEAT JIP* John Innes Potting Compost.
TABLE VII
Compound Table BR WW RC AP MZ TO TO* TO+ No.
14 I NT NT NT NT NT NT 2AT 2AT 15 I 1 2A NT 1AT 1AT 16 1 I | NT NT NT NT NT 3A NT NT 22 I NT NT NT 1A NT NT NT 61 I NT NT NT 1 NT NT 1 132 ! I I NT NT NT NT 1 1 138 I 3 NT NT 139 I I NT NT 110 0 z I G NT NT KEY * 2000 ppm + 500 ppm Retardation 1-3 where 1 = 10-30% 2 = 21-60% 3 = 61-100% Greening effect = G Apical damage = A Tillering or side shooting = T Blank means less than 10% effect NT indicates that the compound was not tested against this species EXAMPLE 16 This Example illustrates the insecticidal properties of certain of the compounds of formula (I).
The activity of each compound was determined using a variety of insect mites and nematode pests. The compound was used in the form of liquid preparations containing from 100 to 500 parts per million (ppm) by weight of the compound. The preparations were made by dissolving the compound in acetone and diluting the solutions with water containing 0.18 by weight of a wetting agent sold under the trade name "SYNPERONIC" NX until the liquid preparations contained the required concentration of the product.
"SYNPERONIC" 15 a Registered Trade Mark.
The test procedure adopted with regard to each pest was basically the same and comprised supporting a number of the pests on a medium which was usually a host plant or a food stuff on which the pests feed, and treating either or both the pests and the medium with the preparations. The mortality of the pests was then assessed at periods usually varying from one to seven days after the treatment.
The results of the tests are given in Table IX for each of the products, at the rate in parts per million given in the second column as a grading of mortality designated as 9, 5 or 0 wherein 9 indicates 80-100% mortality (70-1008 root-knot reduction as compared to untreated plants for Meloidogyne incognita, 5 indicates 5079% mortality (50-69% root-knot reduction for Meloidogyne incognita) and 0 indicates less than 50% mortality (rootknot reduction for Meloidogyne incognita).
In Table IX the pest organism used is designated by a letter code and the pests species, the support medium or food, and the type and duration of test is given in Table VIII.
TABLE VIII
CODE TEST SPECIES SUPPORT TYPE OF DURATION LETTERS MEDIUM/FOOD TEST TUe Tetranychus uritcae French bean Contact 3 (apider mites and ova) leaf CP Chilo partellus Oil seed rape Residual 3 (maize stem borers) leaf DB Diabrotica balteata Filter paper/ Residual 3 (rootworm larvae) maize seed MD Musca domestica Cotton wool/ Contact 1 (houseflies - adults) sugar MI Meloidogyne incognita Semi in-vitro Residual 7 (tomato root knot eelworm - larvae) TABLE IX
COMPOUND RATE OF SPECIES (see Table VIII) NO. APPLICATION TUe CP DB MD MI 14 500 0 9 5 9 15 500 0 - 9 0 250 - - - - 9

Claims (15)

1. A compound having the formula (I) and stereoisomers thereof, wherein W is a substituted pyridinyl or substituted pyrimidinyl group linked to A by any one its ring carbon atoms; A 5 either an oxygen atom or S( )n wherein n is 0, 1 or 2;X, Y and Z, which are the same or different, are hydrogen or halogen atoms, or hydroxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted aryl, optionally substituted alkynyl, optionally substituted alkoxy, optionally substituted alkylthio, optionally substituted aryloxy, optionally substituted arylalkoxy, optionally substituted acyloxy, optionally substituted amino, optionally substituted acylamino, nitro, cyano, -CG2R3, -CONR4R5, -COR6 or -S(O) mR7 (wherein m is 0, 1 or 2) groups, or any two of the groups X, Y and Z, when they are in adjacent positions on the phenyl ring, join to form a fused ring, either aromatic or aliphatic, optionally containing one or more heteroatoms;R1 and R2, which are the same or different, are optionally substituted alkyl groups; provided that when W is 5trifluoromethylpyridin-2-yl, A is oxygen, X is hydrogen, and R1 and R2 are both methyl, Y and Z are not both hydrogen, Y is not F, C1, methyl, nitro, 5-CF3, 5-SCH3 or 4-(CH3)2N if Z is hydrogen and Y and Z together are not 3-nitro-5-chloro, 3,5-dinitro, 4,5 dimethoxy or 4,5-methylenedioxy; and R3, R4, R5, R6 and R7 which are the same or different, are hydrogen atoms or optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl or optionally substituted aralkyl groups; and metal complexes thereof. 2. A compound having the formula (I) and stereoisomers thereof, wherein W is a substituted pyridinyl or a substituted pyrimidinyl group linked to by any one of its carbon atoms and bearing substituents as defined above; A is either an oxygen atom or S(O)n wherein n is 0, 1 or 2; X, Y and Z, which are the same or different, are hydrogen, fluorine, chlorine or bromine atoms, or C14 alkyl, C25 alkenyl, C25 alkynyl, phenyl, C14 haloalkyl, C14 alkoxy, phenoxy, benzyloxy or mono- or dialkylamino groups, or any two of the groups X, Y and Z, when they are in adjacent positions on the phenyl ring, join to form a fused aromatic ring; wherein the aliphatic moieties of any of the foregoing are optionally substituted with one or more C14 alkoxy groups, fluorine, chlorine or bromine atoms, phenyl rings which themselves are optionally substituted, heterocyclic rings which are either aromatic or non-aromatic and are themselves optionally substituted, nitro, amino, cyano, hydroxyl or carboxyl groups, and wherein the phenyl moieties of any of the foregoing are optionally substituted with one or more fluorine, chlorine or bromine atoms, phenyl rings, C14 alkyl, C14 alkoxy, nitro, amino, cyano, hydroxyl or carboxyl groups; and R1 and R2, which are the same or different, are C14 alkyl each optionally substituted with one, two or three halogen atoms provided that when W is 5-trifluoromethylpyridin-2-yl, A is oxygen, X is hydrogen, and R1 and R2 are both methyl, Y and Z are not both hydrogen, Y is not F, C1, methyl, nitro, 5-CF3, 5-SCH3 or 4-(CH3)2N if Z is hydrogen and Y and Z together are no= 3-nitro-5 chloro, 3,5-dinitro, 4,5-dimethoxy or 4,5 methylenedioxy; 3.A compound having the formula (Ia) and stereoisomers thereof, wherein A is S( )n wherein n is 0, 1 or 2, or preferably, an oxygen atom; W is a substituted pyridinyl or a substituted pyrimidinyl group linked to A by any one of its carbon atoms, the substituents on the pyridyl or pyrimidinyl rings, which are the same or different, being one or more halogen atoms, or hydroxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted aryl, optionally substituted alkynyl, optionally substituted alkoxy, (including haloalkoxy), optionally substituted aryloxy, optionally substituted heterocyclyloxy, optionally substituted aryl, optionally substituted heterocyclyl, optionally substituted acyloxy, optionally substituted amino, optionally substituted acylamino, nitro, cyano, Co2R3, -CoNR4R5, -COR6 or s(o)mR7 (wherein m is 0, 1 or 2) groups provided that when W is 5 trifluoromethylpyridin-2-yl, A is oxygen, X is hydrogen, and R1 and R2 are both methyl, Y and Z are not both hydrogen, Y is not F, C1, methyl, nitro, 5 CF3, 5-SCH3 or 4-(CH3)2N if Z is hydrogen and Y and Z together are not 3-nitro-5-chloro, 3,5-dinitro, 4,5 dimethoxy or 4,5-methylenedioxy; and R3, R4, R5, R6 and R7 are as defined above. 4. A compound of the formula (Ib) wherein Q is methyl, trifluoromethyl, (but not 5 trifluoromethyl), methoxy, fluorine, chlorine or bromine. 5. A process for preparing a compound of the formula (I) according to claim 1, which comprise, (i) treating a compound of formula (III) when R8 is a metal atom, with a species of formula R2 L in a suitable solvent, or when R8 is hydrogen, successively with a base and a species of formula R2-L in a suitable solvent, or (ii) eliminating the elements of the alkanol R20H from an acetal of formula (XIII) under acidic or basic conditions, or (iii) reacting a compound of formula (IX) with a compound of formula W-L in the presence of a base and optionally a transition metal or transition metal salt catalyst in a convenient solvent, or (iv) treating a ketoester of formula (XV): : with a phosphorane of formula Ph3PCHOR2 in a convenient solvent; in which W, X, Y, Z, R1 and R2 have the meanings given in claim 1, > is a halogen atom or another good leaving group and Ph is phenyl. 6. The intermediate chemicals of formulae (III)-(V), (IX)-(XV), (XVII), (XIX), (XX) and (XXV) as defined herein. 7. A fungicidal composition comprising, as an active ingredient, a fungicidally effective amount of a compound according to claim 1 and a fungicidally acceptable carrier or diluent therefor. 8. A method of combating fungi which comprises applying to plants or seeds, or to their locus, a compound according to claim 1 or a composition according to claim 7. 9. A plant growth regulating composition comprising, as an active ingredient, an effective amount of a plant growth regulating of formula I as defined in claim 1 and an acceptable carrier or diluent therefor. 10. A method of regulating plant growth which comprises applying to a plant an effective amount of a plant growth regulating compound of formula I according to claim 1. 11. An insecticidal/nematocidal composition comprising an insecticidal or nematocidal compound of formula I as defined in claim 1 in combination with a carrier or diluent. 12. A method of killing or controlling insect and nematode pests which comprises administering to the pest or to a locus thereof an effective amount of an insecticidal compound of formula I as defined in claim 1 or of a composition according to claim 11. Amendments to the claims have been filed as follows
1. Compounds of general formula (II):
and stereoisomers thereof; wherein X, Y and Z, which are the same or different, are hydrogen or halogen atoms, or hydroxy, optionally substituted alkyl (including haloalkyl), optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy (including haloalkoxy), optionally substituted alkylthio, optionally substituted aryloxy, optionally substituted arylalkoxy, optionally substituted acyloxy, optionally substituted amino, optionally substituted acylamino, nitro, cyano, -CO2R , -CONR4R5, -COR6 or -S(O)mR7 (wherein m is 0, 1 or 2) groups, or any two of the groups X, Y and Z, when they are in adjacent positions on the phenyl ring, may join to form a fused ring, either aromatic or aliphatic, optionally containing one or more heteroations; R1 is optionally substituted alkyl; A is either an oxygen atom or S(O)n wherein n is 0, 1 or 2; R3, R , R5, R6 and R7, which are the same or different, are hydrogen atoms or optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl or optionally substituted aralkyl groups;R10 is hydrogen or a protecting group for a phenol or thiophenol group; and R9 is optionally substituted alkyl, hydrogen or a metal atom; provided that: - when R10 is hydrogen then R9 is not hydrogen or a metal atom, - when A is oxygen, R1 and R9 are both methyl and R10 is either hydrogen or a benzyl group then none of X, Y and Z is hydrogen, - when is hydrogen, A is oxygen, R1 is methyl and R10 is a benzyl group then none of X, Y and Z is hydrogen.
2. Compounds as claimed in claim 1 having the general formula (Il):
and steroisomers there of; wherein A is an oxygen atom or S(O)n wherein n is 0, 1 or 2; X, Y and Z, which are the same or different, are hydrogen, fluorine, chlorine or bromine atoms, or C14 alkyl, C2-5 alkenyl, C2-5 alkynyl, phenyl, C1-4 alkoxy, phenoxy, benzyloxy or mono- or dialkylamino groups, or any two of the groups X, Y and Z, when they are in adjacent positions on the phenyl ring, join to form a fused aromatic ring; wherein the aliphatic moieties of any of the foregoing are optionally subtititued with one or more C14 alkoxy groups, fluorine, chlorine or bromine atoms, phenyl rings which themselves are optionally substituted, heterocyclic rings which are either aromatic or non-aromatic and are themselves optionally substituted, nitro, amino, cyano, hydroxyl or carboxyl groups, and wherein the phenyl moieties of any of the foregoing are optionally substituted with one or more fluorine, chlorine or bromine atoms, phenyl rings, C1-4 alkyl, C1-4 alkoxy, nitro, amino, cyano, hydroxyl or 1-@ carboxyl groups; R is C1-4 alkyl optionally substituted with one, two or three halogen atoms;R9 is optionally substituted alkyl, hydrogen or a metal atom; and R10 is hydrogen or a protecting group for a phenol or thiophenol group; provided that: - when R10 is hydrogen then R9 is not hydrogen or a metal atom, - when A is oxygen, R1 and R9 are both methyl and R10 is either hydrogen or a benzyl group then none of X, Y and Z is hydrogen, - when R9 is hydrogen, A is oxygen, R is methyl and 10 R10 is a benzyl group then none of X, Y and z is hydrogen.
3. Compounds as claimed in claim 1 having the general formula (IX):
and steroisomers thereof; wherein X, Y, Z, A and K1 are as defined in claim 1 and R2 is optionally substituted alkyl; provided that when A is an oxygen atom and R1 and R2 are both methyl then none of X, Y and Z is hydrogen.
4. Compounds as claimed in claim 1 having the general formula (IXa):
and stereoisomers thereof; wherein X, Y, Z and A are defined in claim 1; provided that when A is an oxygen atom then none of X, Y and Z is hydrogen.
5. Compounds as claimed in claim 4 having the general formula (IXb):
and stereoisomers thereof; wherein A is S(O) and n is O, 1 or 2.
6. Compounds as claimed in claim 1 having the general formula (X):
and stereoisomers thereof; wherein X, Y, Z and A are as defined in claim 1; R2 is optionally substituted alkyl; and M is a protecting group for a phenol or thiophenol group; provided that when A is an oxygen atom, R1 and R2 are both methyl and M is a benzyl group then none of X, Y and Z is hydrogen.
7. Compounds as claimed in claim 1 having the general formula (Xa):
and stereoisomers thereof; wherein X, Y, Z and A are as defined in claim 1; and M is a protecting group for a phenol or thiophenol group; provided that when A is an oxygen atom and M is a benzyl group then none of X, Y and Z is hydrogen.
8. Compounds as claimed in claim 7 having the general formula (xb):
and stereoisomers thereof; wherein A is S(O) n wherein n is 0, 1 or 2; and M is a protecting group for a phenol or thiophenol group, provided that M is not a benzyl group.
9. Compounds as claimed in claim 8 having the general formula (Xb):
and stereoisomers thereof; wherein A is S(O)n wherein n is O, 1 or 2; and M is a benzyl group.
10. Compounds as claimed in claim 9 having the general formula (Xc):
and stereoisomers thereof; wherein A is S(O)n and n is O, 1 or 2.
11. Compounds as claimed in claim 1 having the general formula (XI):
and stereoisomers thereof; wherein X, Y, Z, A and R1 are as defined in claim 1; K8is hydrogen or a metal atom; and M is a protecting group for a phenol or thiophenol group; provided that when R8 is hydrogen, A is an oxygen atom, R is methyl and M is a benzyl group then none of X, Y and Z is hydrogen.
12. Compounds as claimed in claim 11 having the general formula (XIa):
and stereoisomers thereof; wherein A is an oxygen atom or S( )n wherein n is 0, 1 or 2; R8 is hydrogen or an alkali metal atom; and M is a protecting group for a phenol or thiophenol group; provided that when R8 is hydrogen and A is an oxygen atom then M is not a benzyl group.
13. Compounds as claimed in claim 12 having the general formula (XIa):
and stereoisomers thereof; wherein A is an oxygen atom or S( )n wherein n is 0, 1 or 2; R8 is hydrogen or an alkali metal atom; and M is a benzyl group; provided that when A is an oxygen atom then R8 is not hydrogen.
14. Compounds as claimed in claim 13 having the general formula (XIb):
and stereoisomers thereof; wherein A is an oxygen atom or S( )n wherein n is 0, 1 or 2; and R8 is hydrogen or a sodium atom; provided that when A is an oxygen atom then R8 is not hydrogen.
15. A process for preparing compounds of formula (XI):
wherein M, A, X, Y, Z, R1 and R8 are as defined in claim 11, which comprises treating a compound of formula (XII):
wherein M, A, X, Y and Z are as defined in claim 11, with a base and a formic ester in a suitable solvent at a suitable temperature to give a compound of formula (XI) wherein R8 is a metal atom; and, as appropriate, subsequently treating the compound (XI) so formed with a protic acid to give a compound of formula (XI) wherein R8 is hydrogen.
i6. A process for preparing a compound of formula (X):
wherein M, A, X, Y, Z, R1 and R2 are as defined in claim 6, which comprises: i) treating a compound of formula (XI):
wherein M, A, X, Y, Z and R1 are as defined in claim' 6 and R8 is a metal atom, with a species of formula R2-L, wherein R is as defined in claim 6 and L is a halogen atom or other good leaving group (including nitro), in a suitable solvent; or, ii) successively treating a compound of formula (XI):
wherein M, A, X, Y, Z and R1 are as defined in claim 6 and R8 is hydrogen, with a base and a species of formula R-L, wherein R is as defined in claim 6 and L is a halogen atom or other good leaving group (including nitro).
GB9001442A 1986-04-17 1990-01-22 Intermediates for agriculturally useful acrylic acid derivatives Expired - Fee Related GB2226817B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868609454A GB8609454D0 (en) 1986-04-17 1986-04-17 Fungicides
GB868630825A GB8630825D0 (en) 1986-12-23 1986-12-23 Fungicides
GB8707642A GB2189485B (en) 1986-04-17 1987-03-31 Derivatives of acrylic acid useful in agriculture

Publications (3)

Publication Number Publication Date
GB9001442D0 GB9001442D0 (en) 1990-03-21
GB2226817A true GB2226817A (en) 1990-07-11
GB2226817B GB2226817B (en) 1990-11-28

Family

ID=27262996

Family Applications (4)

Application Number Title Priority Date Filing Date
GB8707642A Revoked GB2189485B (en) 1986-04-17 1987-03-31 Derivatives of acrylic acid useful in agriculture
GB8922842A Revoked GB2223016B (en) 1986-04-17 1989-10-11 2-phenyl-3,3-dialkoxy-propionate derivatives
GB8922843A Expired - Fee Related GB2223017B (en) 1986-04-17 1989-10-11 Pyridine and pyrimidine intermediates
GB9001442A Expired - Fee Related GB2226817B (en) 1986-04-17 1990-01-22 Intermediates for agriculturally useful acrylic acid derivatives

Family Applications Before (3)

Application Number Title Priority Date Filing Date
GB8707642A Revoked GB2189485B (en) 1986-04-17 1987-03-31 Derivatives of acrylic acid useful in agriculture
GB8922842A Revoked GB2223016B (en) 1986-04-17 1989-10-11 2-phenyl-3,3-dialkoxy-propionate derivatives
GB8922843A Expired - Fee Related GB2223017B (en) 1986-04-17 1989-10-11 Pyridine and pyrimidine intermediates

Country Status (4)

Country Link
BR (1) BR8701892A (en)
GB (4) GB2189485B (en)
HK (1) HK10292A (en)
MY (1) MY101728A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0464381A2 (en) * 1990-06-16 1992-01-08 Bayer Ag 2-Methoxyiminocarboxylic acid esters
EP0468695A1 (en) * 1990-07-27 1992-01-29 Zeneca Limited Fungicides
WO1995024396A1 (en) * 1994-03-07 1995-09-14 Zeneca Limited Pyrimidine fungicides
WO1997044325A1 (en) * 1996-05-22 1997-11-27 Basf Aktiengesellschaft 2-(o-[pyrimidin-4-yl]methylene oxy)phenyl acetic acid derivatives and their use in combatting noxious fungi and animal pests
EP1142857A1 (en) * 1998-12-29 2001-10-10 Nippon Soda Co., Ltd. Processes for producing acrylic acid derivative

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0242070A3 (en) * 1986-04-17 1988-12-28 Imperial Chemical Industries Plc Phenyl-acrylic acid ester derivatives, process for their preparation and their use as fungicides
GB2189485B (en) * 1986-04-17 1990-11-28 Ici Plc Derivatives of acrylic acid useful in agriculture
MY100766A (en) * 1986-08-06 1991-02-14 Ici Plc Fungicides.
GB2229720B (en) * 1986-08-20 1991-02-13 Ici Plc Heterocyclic intermediates
DE3904931A1 (en) * 1989-02-17 1990-08-23 Bayer Ag PYRIDYL-SUBSTITUTED ACRYLIC ACID ESTERS
GB9415291D0 (en) * 1994-07-28 1994-09-21 Zeneca Ltd Chemical process
JP2002507197A (en) * 1997-05-30 2002-03-05 ビーエーエスエフ アクチェンゲゼルシャフト Substituted thiopyridine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387923B1 (en) * 1986-04-17 1994-02-16 Zeneca Limited Fungicides
GB2189485B (en) * 1986-04-17 1990-11-28 Ici Plc Derivatives of acrylic acid useful in agriculture

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0464381A2 (en) * 1990-06-16 1992-01-08 Bayer Ag 2-Methoxyiminocarboxylic acid esters
EP0464381A3 (en) * 1990-06-16 1992-01-15 Bayer Ag 2-methoxyiminocarboxylic acid esters
US5312960A (en) * 1990-06-16 1994-05-17 Bayer Aktiengesellschaft Fungicidal 2-methoximinocarboxylic esters
EP0468695A1 (en) * 1990-07-27 1992-01-29 Zeneca Limited Fungicides
CN1036519C (en) * 1990-07-27 1997-11-26 帝国化学工业公司 Fungicides
WO1995024396A1 (en) * 1994-03-07 1995-09-14 Zeneca Limited Pyrimidine fungicides
WO1997044325A1 (en) * 1996-05-22 1997-11-27 Basf Aktiengesellschaft 2-(o-[pyrimidin-4-yl]methylene oxy)phenyl acetic acid derivatives and their use in combatting noxious fungi and animal pests
US6166026A (en) * 1996-05-22 2000-12-26 Basf Aktiengesellschaft 2-(O-[pyrimidin-4-yl]methyleneoxy)phenylacetic acid derivatives and their use in combatting noxious fungi and animal pests
EP1142857A1 (en) * 1998-12-29 2001-10-10 Nippon Soda Co., Ltd. Processes for producing acrylic acid derivative
EP1142857A4 (en) * 1998-12-29 2002-09-11 Nippon Soda Co Processes for producing acrylic acid derivative

Also Published As

Publication number Publication date
GB2189485B (en) 1990-11-28
GB2223016A (en) 1990-03-28
GB2226817B (en) 1990-11-28
GB8922842D0 (en) 1989-11-29
GB2223017A (en) 1990-03-28
GB2189485A (en) 1987-10-28
BR8701892A (en) 1988-02-02
GB2223017B (en) 1991-01-09
HK10292A (en) 1992-01-31
GB9001442D0 (en) 1990-03-21
GB2223016B (en) 1991-01-02
GB8922843D0 (en) 1989-11-29
GB8707642D0 (en) 1987-05-07
MY101728A (en) 1992-01-17

Similar Documents

Publication Publication Date Title
US5633256A (en) Certain pyrimidinyloxy-phenyl acrylates, derivatives thereof and their fungicidal use
US5021581A (en) Fungicides
US5112386A (en) Fungicides
EP0312243B1 (en) Methyl 2-[2-(3-substituted phenoxy)pyridin-3-yl]-3-methoxypropenoatesand their use as fungicides
US4968688A (en) Pyrimidines and their use as fungicides
GB2226817A (en) Intermediates for agriculturally useful acrylic acid derivatives
NZ219750A (en) Acrylic acid derivatives and biocidal compositions
US5221316A (en) Fungicides
GB2222163A (en) Pyridine intermediates
GB2189241A (en) Fungicidal heterocyclic derivatives of acrylic acid
GB2235454A (en) Propanoic acid derivatives
LT3711B (en) Acrylic acid derivatives, processes for preparing thereof and their use

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20020331